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ABSTRACT  
 
It is well known that Mycobacterium tuberculosis, the causative agent of one of the deadliest 
human diseases, tuberculosis, uses human cholesterol as a carbon source both in the latent and 
active phases of its lifestyle.  The discovery of the ability of M. tuberculosis to degrade and use 
cholesterol as a sole source of carbon and energy has opened up the possibility of using 
genes/proteins involved in cholesterol degradation as novel drug targets.  If one can find the 
highly conserved genes/proteins across the mycobacteria that are capable of degrading 
cholesterol, then in future these genes can possibly be used as universal drug targets against 
mycobacterial infections.  However, to date, data on how many mycobacterial species utilise 
cholesterol has not been reported.  Furthermore, performing laboratory experiments is 
laborious and time- and money-consuming, considering each of the mycobacterial species has 
different lifestyle and culture conditions.  The study is aimed at using the available genomic 
data to perform comparative genomic studies to unravel the nature of cholesterol catabolic 
genes/proteins in the genus Mycobacterium to determine which mycobacterial species are 
capable of degrading cholesterol.  This study is a first of its kind comprehensive analysis of the 
genes/proteins involved in cholesterol degradation across 93 mycobacterial species, using 
bioinformatic tools. 
Ninety-three mycobacterial species whose genomes are available for public use at the 
KEGG database were used in this study.  Literature on cholesterol degradation by bacteria was 
collected and the cholesterol degradation pathway was deduced.  The intermediate metabolites 
and enzymes involved in each of the steps were identified and mapped using ChemDraw 
software.  A software program that extracts homolog data across 93 mycobacterial species was 
developed.  The hit proteins’ domains/functions were identified using software programs: 
NCBI Batch Web CD-search tool and the KEGG functional database.  Based on the sequence 
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identity, functional motifs and functional data, if available, the hit proteins were sorted into 
specific enzymatic reactions of cholesterol degradation.  
After thorough literature analysis, 152 genes/proteins were identified as cholesterol 
catabolic genes/proteins and grouped into four different categories. The four categories are: (i) 
genes predicted to be specifically required for growth on cholesterol, (ii) cholesterol catabolic 
genes proven to be or predicted to be essential for the survival of M. tuberculosis in macrophage 
cells and in murine infection, (iii) genes/proteins that are up-regulated during growth on 
cholesterol, and (iv) genes involved in cholesterol degradation by M. tuberculosis H37Rv, but 
not confirmed or predicted to be essential.  In silico analysis of 152 genes across 93 
mycobacterial species revealed that 51 mycobacterial species are unable to degrade cholesterol. 
The specifics on mycobacterial species’ ability to utilise cholesterol, as per their different 
categories, are listed in the table below: 
 
In silico analysis of cholesterol-utilising capability of mycobacterial species 
Category 
No of 
species 
Ability to utilise cholesterol as carbon source 
Negative Positive 
Mycobacterium tuberculosis complex 39 10 29 
Mycobacterium chelonae-abscessus complex 10 10   
Mycobacterium avium complex 15 5 10 
Mycobacteria causing leprosy 2 2   
Nontuberculous mycobacteria 8 5 3 
Saprophytes 19 19   
 
Results from this study are based on the in silico analysis and need to be experimentally 
validated.  
 
Keywords:  Mycobacteria, Species, Cholesterol, Degradation, Breakdown, Genes, Proteins, 
Drug target, Mycobacterium tuberculosis 
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CHAPTER 1 
INTRODUCTION AND LITERATURE REVIEW 
 
1.1. Introduction  
Mycobacterium tuberculosis infection, tuberculosis (TB), is one of the leading causes of death 
worldwide, killing an estimated two million people annually (WHO, 2016; Sotgiu et al., 2017).  
It is estimated that one third of the world’s population (approximately two billion people) is 
infected with this highly pathogenic organism (WHO, 2015).  Once it has entered the human 
body and after ingestion by macrophages, this intracellular pathogen can survive in a modified 
phagosome and cause latent infection for years and sometimes decades without any symptoms 
(Glickman and Jacobs, 2001).  Tubercle bacilli are able to persist in this dormant state, from 
which they may reactivate and cause TB (Glickman and Jacobs, 2001).  The reactivation of 
latent phase M. tuberculosis into the active phase is observed among people whose immune 
system is weakened by human immunodeficiency virus (HIV) infection, use of 
immunosuppressive drugs, malnutrition and/or aging (Flynn and Chan, 2001).  Over the past 
decades, the threat of TB has become greater with the development from single-drug-resistant 
to multiple-drug-resistant (MDR) strains and recently, the surfacing of extensive drug 
resistance (XDR) that threatens to compromise available drugs severely (Migliori et al., 2012).  
With the documentation of total drug-resistant (TDR) strains (Migliori et al., 2012), along with 
the insufficiency of new drug targets, it is clear that more research is needed to discover novel 
drug targets. 
M. tuberculosis can infect, grow and survive in the harsh environment of the 
macrophage and other host cells using mechanisms that are not yet well understood (Clark-
Curtiss and Haydel, 2003; Koul et al., 2004).  Host cholesterol levels are thought to play a role 
in the development of M. tuberculosis infection (Kim et al., 2010), with high levels of 
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cholesterol in the diet significantly enhancing the bacterial burden in the lung (Schäfer et al., 
2009) and impairing immunity to M. tuberculosis (Martens et al., 2008).  Specifically, 
cholesterol is required for the phagocytosis of mycobacteria into macrophages (Gatfield and 
Pieters, 2000; Peyron et al., 2000).  In fact, mycobacteria bind and enter phagocytes through 
cholesterol-enriched membrane microdomains (lipid rafts) (Muñoz et al., 2009).  In addition, 
cholesterol plays a crucial role in the mediation of the infected phagosomal association of 
tryptophan-aspartate-containing coat protein (Pieters and Gatfield, 2002), leading to the 
inhibition of phagosome–lysosome fusion (Nguyen and Pieters, 2005).  This experimental 
evidence suggests an important role for cholesterol during M. tuberculosis infection and 
persistence. 
Research studies demonstrated that M. tuberculosis can grow using cholesterol as the 
sole carbon and energy source (Pandey and Sassetti, 2008).  Therefore, cholesterol has recently 
been identified as an important lipid for mycobacterial infection (De Chastellier and Thilo, 
2006; Ouellet et al., 2011).  The relatively abundant cholesterol distributed in host cells is an 
important growth substrate for these bacteria in different infection stages (e.g. intracellular 
growth or intracellular persistence) (García et al., 2012).  M. tuberculosis growing in human 
cells appears to obtain energy from host lipids rather than other nutrients such as carbohydrates 
(Dubnau et al., 2005).   
In light of the above facts and recent momentum on cholesterol catabolism as a 
therapeutic target in M. tuberculosis, Ouellet et al. (2011) clearly state that more research needs 
to be done in order to understand cholesterol degradation pathways in mycobacteria. 
Especially, comparative genomic studies should be performed to unravel and map the 
cholesterol degradation pathway in different mycobacteria.  If one can find the highly 
conserved genes across the mycobacteria that are capable of degrading cholesterol, then in 
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future these genes can possibly be used as universal drug targets against mycobacterial 
infections. 
 
1.2. Literature Review 
1.2.1. Cholesterol 
Cholesterol is a polycyclic steroid compound that is widely distributed in the biosphere.  This 
27 carbon-atom compound is an amphiphilic lipid, structurally bearing four alicyclic rings and 
the aliphatic side chain.  The side chain is a flat and rigid carbon skeleton fused to four alicyclic 
rings (Figure 1.1.) (García et al., 2012). 
 
 
 
 
 
                              Figure 1.1. The chemical structure of cholesterol. 
 
It is not only abundantly distributed in the biosphere, but also in animals as an essential 
structural component of animal cell membranes (Slaytor and Bloch, 1965) and is required for 
viability and cell proliferation (Dahl and Dahl, 1988; Yeagle, 1993) as well.  Cholesterol plays 
a great physiologic role in plasma membranes.  The most important function of cholesterol in 
the lipid bilayer is to modulate the physicochemical properties of cellular membranes (Yeagle, 
1985; Yeagle, 1988; Finegold, 1992).  This steroid lipid is an abundant structural component 
of cell membranes (Slaytor and Bloch, 1965).  About 20% of membrane lipid is cholesterol 
(Marieb and Hoehn, 2010).  The structural composition of the plasma membrane results in a 
laterally more condensed membrane with increased density of the phospholipids (Lund-Katz 
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et al., 1988; Smaby et al., 1994; McIntosh, 1999).  This increases the mechanical strength and 
decreases the permeability of the membrane (Yeagle, 1985; Needham and Nunn, 1990).  As a 
result, the relatively high rates of both lateral and rotational diffusion of the lipid bilayer are 
maintained (Yeagle, 1988; Vist and Davis, 1990; Davis and Finegold, 1993).  On membranes, 
cholesterol wedges its plate-like hydrocarbon rings between the phospholipid tails, rendering 
stability to the membrane while increasing the mobility of other lipids (Marieb and Hoehn, 
2010) and the fluidity of the membrane (Kusumi et al., 1983 and 1986).  In addition, it also 
raises hydrophobic barriers for polar molecules and increases rigidity barriers for non-polar 
molecules (Subczynski and Wisniewska, 2000).  Moreover, cholesterol can play a role in 
cellular signalling by modulating the physical properties of the lipid bilayer, thereby affecting 
the activity of receptors and enzymes residing on it, or directly as a regulator of enzymes in the 
biosynthesis of cholesterol (Dahl and Dahl, 1988; Jackson et al., 1997; Edwards and Ericsson, 
1998).  
Depending on the physiological demand and biomolecule necessity, cholesterol can be 
catabolised for the biosynthesis of many physiologically important steroids.  Steroids possess 
important biological functions in eukaryotic organisms (Merino et al., 2013).  Some are 
membrane components (e.g., cholesterol and phytosterols), others function as hormones (e.g., 
testosterone and estradiol) and some are bile salts and detergents used in the solubilisation and 
intestinal absorption of fats, cholesterol and lipid-soluble vitamins (Wollam and Antebi, 2011).  
Figure 1.2. illustrates the chemical structure of cholesterol and some biologically important 
steroids derived from cholesterol. 
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  Figure 1.2. Cholesterol and its catabolic products (taken from García et al., 2012). 
 
Cholesterol is naturally abundant in both the hydrosphere and lithosphere.  Although 
ubiquitous in nature, cholesterol is a recalcitrant molecule to biodegradation because of its low 
number of functional groups (one carbon-carbon double bond and a single hydroxyl group), its 
low solubility in water (3×10-8M) and its complex spatial conformation constituted by four 
alicyclic rings and two quaternary carbon atoms (García et al., 2012).  The high rate of ubiquity 
and persistence of cholesterol and some derived compounds such as coprastonol, have been 
used as reference biomarkers for environmental pollution analysis (Veiga et al., 2005). 
Cholesterol and its metabolites have many functions in both prokaryotes and eukaryotes; 
functions relating to biology, medicine and biotechnology. 
 
1.2.2. Mycobacterium tuberculosis and cholesterol 
The ubiquity of cholesterol and related sterols in the environment has made them a common 
carbon source for many different microorganisms, some of them being important pathogens, 
such as M. tuberculosis (García et al., 2012).  The ability of M. tuberculosis to survive in the 
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nutrient-deficient vacuole of the host cell has led to studies identifying its ability to utilise the 
host’s cholesterol as an important source of carbon (Griffin et al., 2012).   
In order to understand how M. tuberculosis uses cholesterol, research has been 
intensified to understand the cholesterol degradation pathway. However, cholesterol 
catabolism by bacteria has not yet been fully elucidated in any of the bacterial strains having 
cholesterol degrading abilities, thus the metabolic pathways are suggested by merging 
biochemical and genetic studies done on different organisms.  Based on the available data, the 
cholesterol degradation pathway in M. tuberculosis can be divided into two major phases: (i) 
initial degradation of the aliphatic side chain, and (ii) subsequent degradation of the A–D rings 
(Figure 1.3.) (Ouellet et al., 2011).  It remains unclear whether there is an obligatory order of 
the degradation reactions in M. tuberculosis.  The evidence obtained from the literature on 
rhodococcal sterol catabolism suggests that intermediates of ring and side chain degradation 
can be exchanged between the two pathway branches (Rosłoniec et al., 2009).  However, the 
situation seems to differ in M. tuberculosis, as blockage of the side chain degradation resulted 
in the accumulation of cholest-4-en-3-one as a major metabolite (Ouellet et al., 2011), 
suggesting that the ring-degrading enzymes (e.g. KsaAB and HsaA-C) act optimally after the 
side chain is removed. 
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Figure 1.3. Proposed degradation pathway and flux of metabolites derived from catabolism of 
the cholesterol aliphatic side chain and ring nucleus (taken from Ouellet et al., 2011). 
 
1.2.3. Genes/proteins involved in the cholesterol degradation by M. tuberculosis 
To proliferate within the macrophages, M. tuberculosis cells undergo a shift in metabolism 
from using carbohydrates to primarily using host lipids (Pandey and Sassetti, 2008; Nesbitt et 
al., 2010).  With determination of the complete genome of M. tuberculosis, revealing at least 
250 genes predicted to be involved in lipid metabolism (Cole et al., 1998), and recent 
identification of a large regulon of cholesterol catabolic genes, a lot of time has been devoted 
to identify and annotate these specific genes in the search for possible novel drug targets against 
this organism.  Van Der Geize et al. (2007) identified a complete set of genes required for 
cholesterol degradation in Rhodococcus jostii.  Furthermore, they identified these 51 up-
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regulated proteins in M. tuberculosis and M. bovis Bacillus Calmette-Guérin (BCG). This 
suggests that cholesterol catabolic genes are conserved among mycobacterial species.  For 
annotation of the cholesterol catabolic genes they compared the sequence similarity of the gene 
products of R. jostii RHA1 and M. tuberculosis H37Rv strains and compiled a list of genes 
predicted to be involved in cholesterol catabolism (Table 1.1.) (Van Der Geize et al., 2007).  
They further stated that hsd4A, hsd4B, fadD19, fadE26 and ltp3 comprise one set of these genes 
that is highly up-regulated and encodes all of the enzymes necessary to perform one full cycle 
of β-oxidation (Van Der Geize et al., 2007).  Up-regulated to a lesser extent, is a second 
incomplete set of β-oxidation genes, echA19, fadD17, fadE27 and ltp4, that are probably also 
involved in side chain degradation (Van Der Geize et al., 2007). 
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Table 1.1. Annotation of RHA1, H37Rv and BCG genes assigned to cholesterol pathway 
(taken from Van Der Geize et al., 2007).  
 
Notes: 
a Name assigned based on current study. 
b Identification number for the RHA1 gene. 
c Identification number for the reciprocal best hit in M. tuberculosis H37Rv. 
d Identification number for the reciprocal best hit M. bovis BCG. 
Gene
a
RHA1
b
H37Rv
c
BCG
d
Identity
e Annotation of gene product Best hit
f
Identity
g
mce4F Ro04703 Rv3494c Bcg3558c 37 MCE family protein NA NA
mce4E Ro04702 Rv3495c Bcg3559c 35 MCE family protein NA NA
mce4D Ro04701 Rv3496c Bcg3560c 43 MCE family protein NA NA
mce4C Ro04700 Rv3497c Bcg3561c 41 MCE family protein NA NA
mce4B Ro04699 Rv3498c Bcg3562c 46 MCE family protein NA NA
mce4A Ro04698 Rv3499c Bcg3563c 41 MCE family protein CAA50257 32
supB Ro04697 Rv3500c Bcg3564c 66
Sterol uptake permease subunit 
(ABC transporter)
AAT51760 49
supA Ro04696 Rv3501c Bcg3565c 72
Sterol uptake permease subunit 
(ABC transporter)
AAT51759 55
choD Ro04305 Rv3409c Bcg3479c 60 Cholesterol oxidase P12676 19
hsd4A Ro04695 Rv3502c Bcg3566c 59 17β-hydroxysteroid dehydrogenase BAD66689 36
hsd4B Ro04531 Rv3538 Bcg3602 62 2-Enoyl acyl-CoA hydratase CAA55037 30
kshA Ro04538 Rv3526 Bcg3590 59
Ketosteroid-9α-hydroxylase, 
oxygenase
AAL96829 57
kshB Ro05833 Rv3571 Bcg3636 54
Ketosteroid-9α-hydroxylase, 
reductase
AAL96830 69
kstD Ro04532 Rv3537 Bcg3601 62 3-Ketosteroid-Δ1-dehydrogenase AAL82579 40
hsaB Ro04542 Rv3567c Bcg3632c 70 3-HSA hydroxylase, reductase BAC67692 16
hsaC Ro04541 Rv3568c Bcg3633c 81 3,4-DHSA dioxygenase BAB15809 42
hsaD Ro04540 Rv3569c Bcg3634c 75 4,9-DSHA hydrolase BAC67693 31
hsaA Ro04539 Rv3570c Bcg3635c 76 3-HSA hydroxylase, oxygenase BAC67691 37
hsaF Ro04535 Rv3534c Bcg3598c 79 4-Hydroxy-2-oxovalerate aldolase P51017 48
hsaG Ro04534 Rv3535c Bcg3599c 85 Acetaldehyde dehydrogenase BAB97164 61
hsaE Ro04533 Rv3536c Bcg3600c 71 2-Hydroxypentadienoate hydratase BAB97166 59
fadE26 Ro04693 Rv3504 Bcg3568 77 Acyl-CoA dehydrogenase P71539 25
fadE27 Ro04692 Rv3505 Bcg3569 54 Acyl-CoA dehydrogenase P16219 24
fadD17 Ro04691 Rv3506 Bcg3570 56 Fatty acid-CoA synthetase Q4LDG0 20
fadD19 Ro04689 Rv3515c Bcg3578c 64 Fatty acid-CoA ligase AAB87139 38
echA19 Ro04688 Rv3516 Bcg3579 73 Fatty acid-CoA hydratase P31551 33
ltp4 Ro04684 Rv3522 Bcg3586 72 3-Ketoacyl-CoA thiolase NA NA
ltp3 Ro04683 Rv3523 Bcg3587 79
SCPx related 3-ketoacyl-CoA 
thiolase
AAA40098 20
Ro06698 NA NA NA Cyclohexanone monooxygenase AAG01290 59
Ro06693 NA NA NA 5-Valerolactone hydrolase BAC22650 68
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e Percent amino acid sequence identity of the RHA1 and H37Rv and BCG orthologues based on full sequence 
alignment. Nucleotide sequence identity between H37Rv and BCG genes is >98%. 
f Accession number of functionally characterised best hit in National Center for Biotechnology Information 
database. 
g Percentage amino acid sequence identity of the RHA1 enzyme and its experimentally characterised best hit based 
on full sequence alignment. NA, not available (either no homologous gene in H37Rv or BCG, or no functionally 
characterised homolog reported). 
 
Griffin et al. (2011) used high-resolution phenotypic profiling with highly parallel 
Illumina sequencing to characterise transposon libraries in order to identify the genes that are 
important for the growth of M. tuberculosis precisely.  This deep sequencing-based mapping 
approach allowed them to identify 96 genes that are predicted to be important for growth on 
cholesterol (Table 1.2.). 
 
Table 1.2. Genes predicted to be specifically required for growth on cholesterol (taken from 
Griffin et al., 2011). 
Locus Synonym 
 
Locus Synonym 
 
Locus Synonym 
Rv0009 ppiA 
 
Rv1919c - 
 
Rv3526 kshA 
Rv0153c ptbB 
 
Rv1963c mce3R 
 
Rv3531c - 
Rv0202c mmpL11 
 
Rv2048c pks12 
 
Rv3534c hsaF 
Rv0244c fadE5 
 
Rv2118c - 
 
Rv3536c hsaE 
Rv0362 mgtE 
 
Rv2206 - 
 
Rv3537 kstD 
Rv0391 metZ 
 
Rv2239c - 
 
Rv3540c ltp2 
Rv0450c mmpL4 
 
Rv2416c eis 
 
Rv3542c - 
Rv0485 - 
 
Rv2462c tig 
 
Rv3543c fadE29 
Rv0495c - 
 
Rv2506 - 
 
Rv3544c fadE28 
Rv0655 mkl 
 
Rv2668 - 
 
Rv3545c cyp125 
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Locus Synonym 
 
Locus Synonym 
 
Locus Synonym 
Rv0693 pqqE 
 
Rv2681 - 
 
Rv3546 fadA5 
Rv0694 lldD1 
 
Rv2684 arsA 
 
Rv3548c - 
Rv0695 - 
 
Rv2710 sigB 
 
Rv3549c - 
Rv0696 - 
 
Rv2799 - 
 
Rv3551 - 
Rv0761c adhB 
 
Rv2914c pknI 
 
Rv3553 - 
Rv0805 - 
 
Rv2985 mutT1 
 
Rv3559c - 
Rv0876c - 
 
Rv3050c - 
 
Rv3560c fadE30 
Rv1071c echA9 
 
Rv3274c fadE25 
 
Rv3561 fadD3 
Rv1084 - 
 
Rv3419c gcp 
 
Rv3563 fadE32 
Rv1096 - 
 
Rv3421c - 
 
Rv3564 fadE33 
Rv1129c - 
 
Rv3492c - 
 
Rv3568c hsaC 
Rv1130 - 
 
Rv3493c - 
 
Rv3569c hsaD 
Rv1131 gltA1 
 
Rv3494c mce4F 
 
Rv3570c hsaA 
Rv1183 mmpL10 
 
Rv3495c lprN 
 
Rv3571 kshB 
Rv1193 fadD36 
 
Rv3496c mce4D 
 
Rv3572 - 
Rv1428c - 
 
Rv3497c mce4C 
 
Rv3573c fadE34 
Rv1432 - 
 
Rv3498c mce4B 
 
Rv3575c - 
Rv1608c bcpB 
 
Rv3499c mce4A 
 
Rv3779 - 
Rv1626 - 
 
Rv3500c yrbE4B 
 
Rv3820c papA2 
Rv1627c - 
 
Rv3501c yrbE4A 
 
Rv3824c papA1 
Rv1798 - 
 
Rv3502c hsd4A 
 
Rv3825c pks2 
Rv1906c - 
 
Rv3515c fadD19 
 
Rv3911 sigM 
 
 
In M. tuberculosis, 41 of the steroid catabolic pathway genes, including those involved 
in the A and B rings’ degradation, are specifically up-regulated during survival in the 
macrophages (Van Der Geize et al., 2007). 
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Expression of many of these cholesterol catabolic genes of M. tuberculosis has been 
shown to be controlled by two TetR-type transcriptional repressors, kstR and kstR2 (Figure 
1.4.) (Kendall et al., 2010; Ouellet et al., 2011).  KstR controls the expression of most of the 
genes found in two chromosomal segments, Rv3494c – Rv3547 and Rv3566c – Rv3574, but 
there are many other KstR-regulated genes spread throughout the M. tuberculosis genome, 
including Rv1106c that codes for 3β-hydroxysteroid dehydrogenase (3β-HSD) – one of the first 
enzymes involved in cholesterol degradation by this organism (Figure 1.3.) (Ouellet et al., 
2011).  It was shown that kstR2 (Rv3557c) controls the expression of a subset of 15 genes 
(Rv3548 – Rv3565) within the kstR regulon (Kendall et al., 2010).  Both KstR and KstR2 
negatively autoregulate themselves, but they act independently of each other (Kendall et al., 
2010). 
Also playing a crucial role in the pathogenesis is the igr locus (Figure 1.4.), which is 
required for intracellular growth (therefore named igr for intracellular growth) of 
M. tuberculosis in macrophages and mice and essential for cholesterol metabolism, since igr-
deficient bacteria cannot grow using cholesterol as a primary carbon source (Chiang et al., 
2007; Chang et al., 2009; Miner et al., 2009).  The igr operon is made up of six genes – cyp125 
(a cytochrome P450), fadE28 and fadE29 (two probable acyl-CoA dehydrogenases, Rv3544c 
and Rv3543c), Rv3541-2c (two conserved hypothetical proteins, also thought to be putative 
enoyl-CoA hydratases) and ltp2 (a putative lipid carrier protein, Rv3540c) (Ouellet et al., 2011; 
García-Fernández et al., 2013).  In research done by Thomas et al. (2011) they concluded, 
based on the structure of the isolated metabolite, enzyme activity and bioinformatic 
annotations, that the igr operon is necessary to completely metabolise the side chain of 
cholesterol metabolites. 
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Figure 1.4. The cholesterol catabolic genes of M. tuberculosis (taken from Ouellet et al., 2011). 
Assigned or proposed catalytic activities of genes are colour-coded:  red = uptake, magenta = side-chain 
degradation, green = AB-rings degradation, blue = β-oxidation, orange = transcriptional regulator, black = 
unassigned function, grey = not regulated by KstR or KstR2.  * Genes predicted to be essential for survival in 
macrophage cells and in murine infection.  # Genes proven to be essential for survival in macrophage cells and in 
murine infection.  Abbreviations: ABC-transporter, ATP-binding cassette transporter; PE, protein-containing Pro-
Glu motifs; PE-PGRS, protein consisting of the PE domain followed by a C-terminal extension with multiple 
tandem repetitions of Gly-Gly-Ala or Gly-Gly-Asn; CHP, conserved hypothetical protein; HP, hypothetical 
protein; PPE, protein containing Pro-Pro-Glu motifs. 
 
Like most bacteria, M. tuberculosis does not make its own sterols, but research has 
shown that cholesterol is required for infection and that the mycobacteria can use cholesterol 
as a sole source of carbon (Brzostek et al., 2009; Ouellet et al., 2011).  An ABC-like transport 
system, coded by mce4 genes, was identified to be involved in cholesterol import into M. 
tuberculosis (Ouellet et al., 2011).  There are actually four mce gene clusters (mce1-4) that 
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consist of 12-gene operons (Rengarajan et al., 2005).  The Mce4 transport system is essential 
for cholesterol transport into bacterial cells and also plays an important role in pathogenesis, 
since a mutant lacking this transporter fails to persist in the lungs of chronically infected mice 
and cannot grow in (IFN-λ)-activated macrophages (Pandey and Sassetti, 2008). This means 
that the Mce4 transport system transports host cholesterol into the bacterial cell where 
cholesterol is degraded to produce energy for the bacteria to survive and cause disease.  Also, 
the ability of Mce4 proteins to bind cholesterol could act as a signal allowing the pathogen to 
interact with the host (Mohn et al., 2008).  
Cholesterol-degrading enzymes also play a crucial role in the pathogenesis.  For 
instance, the cholesterol oxidase (ChOx) from Rhodococcus equi, a primary pathogen of horses 
and an opportunistic pathogen of humans, has been described as the major membrane-
damaging factor (Navas et al., 2001), although its role in pathogenesis is controversial (Pei et 
al., 2006).  The cholesterol oxidase found in M. tuberculosis also appears to be important for 
the growth of the pathogen in peritoneal macrophages and lungs of mice (Brzostek et al., 2005). 
Using 14C-labeled cholesterol derivatives in the investigation of cholesterol degradation 
by M. tuberculosis, it was shown that the carbon atoms from the sterol framework go to energy 
production and the ones from the aliphatic side chain go to lipid synthesis (Pandey and Sassetti, 
2008), increasing the lipid virulence factor phthiocerol dimycocerosate (PDIM) in the organism 
cell wall (Yang et al., 2009). 
 
1.2.4. Side chain degradation 
It is generally accepted that the cholesterol side chain is shortened by β-oxidation reactions 
(Ouellet et al., 2011).  Before the saturated side chain of cholesterol can enter into the 
M. tuberculosis β-oxidation pathway, it must first be chemically functionalised at the 
ω-position (Ouellet et al., 2011).  Of the four chemical steps necessary to prepare the side chain 
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for β-oxidation, the first three are oxidation reactions catalysed by cytochrome P450 enzymes 
CYP125 (Rv3545c), CYP142 (Rv3518c) and CYP124 (Rv2266) (Figure 1.3.) (Rosłoniec et al., 
2009; Ouellet et al., 2011).  They are capable of oxidising the side chains of cholesterol and 
cholest-4-en-3-one to the terminal alcohol (by introducing a hydroxyl group onto the side 
chain), aldehyde and carboxylic acid metabolites (Ouellet et al., 2011).  A sterol-CoA ligase 
catalyses the final ATP-dependent step (Ouellet et al., 2011).   
Research has demonstrated that CYP125 does not play a key role in cholesterol 
catabolism in the M. tuberculosis H37Rv strain and suggests that this strain possesses 
compensatory activities (Johnston et al., 2010).  However, investigation of the in vitro enzyme 
specificities found that CYP125 and CYP142 are the dominant P450 enzymes responsible for 
initiating sterol side chain degradation in M. tuberculosis (Johnston et al., 2010), although in 
the CDC1551 strain, CYP142 is present as a pseudogene (García-Fernández et al., 2013).  In 
vitro analysis has also demonstrated that CYP142 can support the growth of the H37Rv strain 
on cholesterol in the absence of cyp125A1 (Johnston et al., 2010).  Using western blot analysis, 
they found that CYP124A1 was not detectably expressed in the H37Rv or CDC1551 strains, 
but CYP142 was found in H37Rv and not in CDC1551 (Johnston et al., 2010).  In the absence 
of CYP125 or CYP142, cholest-4-en-3-one accumulates and inhibits bacterial growth on 
cholesterol (Ouellet et al., 2011).   
β-Oxidation  is the pathway of the breakdown of fatty acids in the form of acyl-CoA 
molecules, i.e. the metabolic pathway of fatty acids oxidation (Figure 1.5.) (Świzdor et al., 
2012).  Before the oxidative reactions of the β-oxidation cycle, the fatty acid is activated in a 
reaction catalysed by an ATP-dependent ligase, to its thioester with coenzyme A (CoA).  The 
thioester then undergoes dehydrogenation catalysed by acyl-CoA dehydrogenase to form the 
enoyl-CoA, which is then hydrated to the hydroxyacyl-CoA by enoyl-CoA hydratase.  3-
Hydroxyacyl-CoA dehydrogenase then catalyses the oxidation of the hydroxyl group.  The 
© Central University of Technology, Free State
CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
  
16 | P a g e  
 
thiolase described in the next step by Świzdor et al., (2012) to catalyse the thiolytic cleavage 
of β-ketoacyl-CoA into two molecules of acyl-CoA as products, seems to correspond to the 
FadA5 described below.  A single round of the β-oxidation cycle of unbranched chain fatty 
acids produces acetyl-CoA and a CoA thioester of an acid shorter by two carbon atoms.  The 
shortened fatty acyl-CoA then undergoes a further round of the β-oxidation cycle. 
 
 
           Figure 1.5. Scheme of the β-oxidation cycle (taken from Świzdor et al., 2012). 
 
Genes believed to be encoding β-oxidation enzymes have been identified in the 
cholesterol regulons of M. tuberculosis (Ouellet et al., 2011).  One of these enzymes, a thiolase 
encoded by fadA5, catalyses the thiolysis of acetoacetyl-CoA in vitro, which is consistent with 
removal of the side chain by β-oxidation, producing androstene metabolites, androst-4-ene-
3,17-dione (AD) and androsta-1,4-diene-3,17-dione (ADD) (Figure 1.3.) (Nesbitt et al., 2010).  
This activity is required for growth on cholesterol and virulence, especially during the late 
(chronic) stage of mouse infection, prior to the onset of the immune response (Nesbitt et al., 
2010; García-Fernández et al., 2013).  Another set of enzymes, acyl-CoA dehydrogenases, is 
required to catalyse unsaturation reactions in β-oxidation of steroid-CoA substrates, and the M. 
tuberculosis genome contains six sets of these enzyme genes (fadE’s) (Wipperman et al., 
2013).  Regulated by cholesterol, each set of these genes is found adjacent to another within 
the same operon (Wipperman et al., 2013). 
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According to Schnappinger et al. (2003), their research indicated the induction of 18 
genes predicted to encode all the enzymes necessary for the biochemical activation and 
β-oxidation of fatty acids, including fatty acid-CoA synthase (fadD3, fadD9, fadD10, fadD19), 
acyl-CoA dehydrogenase (fadE5, fadE14, fadE22-24, fadE27-29, fadE31), enoyl-CoA 
hydratase (echA19), hydroxybutyryl-CoA dehydrogenase (fadB2, fadB3), and acetyl-CoA 
transferase (fadA5, fadA6). 
Griffin et al. (2011) also found that hsd4A, another predicted β-oxidation gene, is 
required for growth on cholesterol, along with ltp2, fadE29, fadE28, fadA5, fadE30, fadE32, 
fadE33, fadE34, hsd4B and also fadE5, echA9, fadD36 and fadE25.   
 
1.2.5. Sterol ring degradation 
The first step in the breakdown of the sterol ring is the conversion of cholesterol to cholest-4-
en-3-one (Figure 1.3.) (Ouellet et al., 2011).  This reaction may be catalysed by either a 
3β-HSD or a cholesterol oxidase (ChoD) (Ouellet et al., 2011).  As mentioned earlier, Rv1106c 
encodes a 3β-HSD.  This enzyme uses NAD+ as a cofactor and oxidises cholesterol (among 
others) to its 3-keto-4-ene product, cholest-4-en-3-one (Ouellet et al., 2011).  Rv3409c encodes 
ChoD and is required for M. tuberculosis virulence (Brzostek et al., 2007).  However, in a 
study by Yang et al. (2011) they found that Rv3409c is not required for growth on cholesterol 
as a sole carbon source and concluded that 3β-HSD is required for the initial conversion of 
cholesterol and that a second ChoD activity is not present in M. tuberculosis.  In addition to 
this, mice infection experiments confirmed the significance of ChoD in the pathogenesis of M. 
tuberculosis, where it drives the oxidation of 3β-hydroxy-5-ene to 3-keto-4-ene (Brzostek et 
al., 2007).   
3-ketosteroid-Δ1-dehydrogenase (Δ1KstD) is assumed to be coded by the Rv3537 gene 
that is part of the cholesterol regulon (Van Der Geize et al., 2007; Ouellet et al., 2011).  This 
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enzyme catalyses the trans-axial elimination of the C1(α) and C2(β) hydrogen atoms (C1-C2 
dehydrogenation) of the 3-ketosteroid A ring of 4-androstenedione (AD) to yield 1,4-
androstenedione (ADD) (Figure 1.3.) (Ouellet et al., 2011) and targeted disruption of this gene 
inhibited growth on cholesterol (Brzostek et al., 2009).  In research done by Brzostek et al. 
(2009) they found direct evidence that M. tuberculosis degrades cholesterol exclusively via the 
AD/ADD intermediates and that KstD plays an essential role in this process. 
In the next step, 9-hydroxylation of the 3-ketosteroid is catalysed by KshAB (3-
ketosteroid 9α-hydroxylase), a two-component Rieske oxygenase (Figure 1.3) (Petrusma et al., 
2014).  KshA (Rv3526) is the oxygenase component and KshB (Rv3571) is the reductase 
component (Petrusma et al., 2014).  Research has shown that ΔkshA and ΔkshB deletion 
mutants were unable to utilise cholesterol and are essential in M. tuberculosis pathogenicity 
(Hu et al., 2010). 
These two steps – the 9-hydroxylation of the 3-ketosteroid together with the C1-C2 
dehydrogenation – are key to opening of the B ring and aromatisation of the A ring via 
9-hydroxy-1,4-androstene-3,17-dione (9OHADD) (Figure 1.3.) (Ouellet et al., 2011).  This 
intermediate is unstable and spontaneously hydrolyses to 3-hydroxy-9,10-secoandrosta-
1,3,5(10)-triene-9,17-dione (3-HSA) (Petrusma et al., 2014).   
The hsaACDB genes in M. tuberculosis are part of a single operon (Dresen et al., 2010) 
and transposon mutagenesis studies have indicated that their activity is critical for the survival 
of M. tuberculosis in macrophages (Rengarajan et al., 2005; Dresen et al., 2010).  The hsaA 
and hsaB genes encode for a putative oxygenase and reductase, respectively, of a flavin-
dependent mono-oxygenase that hydroxylates (C4-hydroxylation) 3-HAS, a phenol, to a 
catechol, 3,4-dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione (3,4-DHSA) (Figure 
1.3) (Dresen et al., 2010).  3,4-DHSA is then oxygenated and cleaved by HsaC, an iron-
dependent extradiol dioxygenase, to produce 4,5-9,10-diseco-3-hydroxy-5,9,17-
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trioxoandrosta-1(10),2-dien-4-oic acid (4,9-DSHA) (Figure 1.3) (Ouellet et al., 2011).  When 
this enzyme that fragments ring A of the sterol is interrupted, the toxic catechol intermediate 
accumulates (Ouellet et al., 2011).  HsaD, a member of the α/β hydrolase family, is involved 
in the aerobic degradation of aromatic compounds in microbes and is coded by hsaD, one of 
the genes identified to be required for survival in macrophages (Ouellet et al., 2011).  It is 
proposed to catalyse the hydrolysis of a carbon-carbon bond in 4,9-DSHA to yield 9,17-dioxo-
1,2,3,4,10,19-hexanorandrostan-5-oic acid (DOHNAA) and 2-hydroxy-hexa-2,4-dienoic acid 
(HHD) (Figure 1.3.).  HHD is then metabolised to tricarboxylic acid cycle intermediates (Lack 
et al., 2010), and propionyl-CoA (Ouellet et al., 2011), probably by HsaEFG (hsaEFG) (Griffin 
et al., 2011), whereas the metabolic fate of DOHNAA (corresponding to the C and D ring 
fragment) is still uncertain (Figure 1.3.) (Lack et al., 2010).  Griffin et al. (2011) identified 
genes fadE28, fadE29 and fadD3 to probably be involved in the degradation of DOHNAA. 
 
1.2.6. Cholesterol catabolism inhibitors 
With increasingly more research demonstrating the importance of cholesterol catabolism in M. 
tuberculosis infection and persistence, targeting this pathway could prove effective in the 
search for novel potential drug targets.  Blockage at certain steps in the pathway has been 
shown to result in cell death or bacteriostasis.   
KshAB, HsaC are particularly attractive enzymes for antimycobacterials, since their inhibition 
causes bacteriotoxicity (Hu et al., 2010, Ouellet et al., 2011).  Research done by Eltis and co-
workers also suggests IpdAB (a predicted CoA transferase involved in the degradation of rings 
CD) as a potential drug target, and they have identified several compounds that strongly inhibit 
HsaC (https://www.microbiology.ubc.ca/research/labs/eltis/research/cholesterol-catabolism-
mycobacterium-tuberculosis).  They also indicate that KshAB, HsaC and IpdAB have no close 
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human homologs, so host toxicity and bacterial cross-resistance are less likely, and since they 
are not targets of current therapies, they might be valuable therapeutic targets. 
With cyp125 predicted as one of the genes specifically required for growth on 
cholesterol (Griffin et al., 2011) and with the inhibition of bacterial growth on cholesterol in 
the absence of CYP125 (Ouellet et al., 2011), it seems to be a promising drug target for 
eliminating non-replicating latent M. tuberculosis (Hudson et al., 2012).  Since CYP142 
counters the growth defect of a CYP125 M. tuberculosis mutant strain on cholesterol, this one 
too may present an additional secondary drug target for latent infections (Johnston et al., 2010).  
Several antifungal azole drugs bind to CYP125 and CYP142 (García-Fernández et al., 2013) 
and research has shown that econazole especially exhibits antimycobacterial activities against 
both latent M. tuberculosis infection and multidrug-resistant strains (Ahmad et al., 2006a and 
b). 
Azasteroids are compounds that inhibit enzymes in steroid biosynthetic pathways and 
inhibition of 3β-HSD for targeting the M. tuberculosis cholesterol catabolic pathway using a 
series of azasteroids was tested, but cross-reactivity with human 3β-HSD necessitates future 
work to develop more M. tuberculosis-specific inhibitors (Thomas et al., 2011). 
 
1.3. Rationale, Aims and Objectives of the Study 
As indicated above, genes/proteins involved in cholesterol degradation are now considered as 
novel drug targets in the fight against the deadly human pathogen, M. tuberculosis.  However, 
to date, studies analysing the cholesterol degradation capability of different species belonging 
to the genus Mycobacterium have not been reported.  Furthermore, performing wet-laboratory 
experiments on a large scale with different mycobacterial species is quite laborious and time- 
and money-consuming, in addition to the special laboratory safety requirements for working 
with certain safety-risk strains.  
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Considering the above facts and taking the advantage of genome sequencing of quite a 
number of mycobacterial species into account, this study aims to perform comprehensive in 
silico comparative analysis of the genes/proteins involved in cholesterol degradation in the 
genus Mycobacterium.  Study results are aimed at identifying mycobacterial species capable 
of using cholesterol as a carbon source.  To achieve this task, a comprehensive cholesterol 
degradation pathway will be deduced from the available literature.  Genes/proteins involved in 
the cholesterol degradation pathway will be identified and comprehensive comparative analysis 
of homolog genes/proteins in different mycobacterial species will be performed using a newly 
developed software program.  Gene/protein sequences will be collected and subjected to 
protein family assignment, phylogenetic and functional analysis.  Finally, based on the 
presence or the absence of genes/proteins that are critical for cholesterol degradation, 
mycobacterial species’ ability to degrade cholesterol will be determined.   
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CHAPTER 2 
ANNOTATION AND CLASSIFICATION OF GENES/PROTEINS INVOLVED IN 
CHOLESTEROL DEGRADATION IN MYCOBACTERIUM TUBERCULOSIS H37RV 
 
2.1. Introduction 
The discovery of the ability of Mycobacterium tuberculosis to degrade and use cholesterol as 
a sole source of carbon and energy has opened up the possibility of using genes/proteins 
involved in cholesterol degradation as novel drug targets (Ouellet et al. 2011).  As discussed 
in Chapter 1, cholesterol degradation by bacteria has not yet been fully elucidated, but from 
the available biochemical and genetic data, the cholesterol degradation pathway for 
M. tuberculosis can be deduced. 
 The current chapter is aimed at deducing the cholesterol degradation pathway and 
classifying the genes/proteins involved in cholesterol degradation by M. tuberculosis H37Rv.   
 
2.2. Methodology 
Articles were collected from different databases, mainly Google Scholar, PubMed and Scopus.  
The literature was reviewed and the data was processed in order to create a schematic diagram 
of the cholesterol degradation pathway by M. tuberculosis H37Rv, showing the intermediate 
metabolites and the enzymes involved in different reactions.  According to Ouellet et al. (2011), 
the cholesterol degradation pathway of M. tuberculosis can be divided into two major phases 
– firstly, the initial degradation of the aliphatic side chain and then the subsequent degradation 
of the A-D rings.  For the purpose of this study, the two phases were drawn up separately, using 
ChemDraw software (Mills, 2006).  
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2.3. Results and Discussion 
2.3.1. Annotation of the cholesterol degradation pathway in M. tuberculosis H37Rv 
As mentioned earlier, the cholesterol degradation pathway in M. tuberculosis can be divided 
into two major phases – the initial degradation of the aliphatic side chain and then the 
degradation of the four alicyclic A-D rings.  It has not been confirmed whether there is a 
specific order to the degradation reactions regarding the side chain and the rings, but for 
M. tuberculosis it has been suggested that the ring-degrading enzymes, KsaAB and HsaA-C, 
act optimally after the side chain has been removed, since blockage of the side chain 
degradation resulted in accumulation of cholest-4-en-3-one as a major metabolite (Ouellet et 
al., 2011). 
 Based on the available literature (Van Der Geize et al., 2007; Nesbitt et al., 2010; 
Griffin et al., 2011; Ouellet et al., 2011; Thomas et al., 2011; Świzdor et al., 2012; 
https://www.microbiology.ubc.ca/research/labs/eltis/research/cholesterol-catabolism-
mycobacterium-tuberculosis), the following schematics (Figures 2.1. and 2.2.) have been 
drawn up using ChemDraw software.  
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Figure 2.2. Cholesterol ring degradation. 
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2.3.2. Classification of genes/proteins involved in cholesterol degradation by 
M. tuberculosis H37Rv 
Based on literature, all genes known to be involved in cholesterol breakdown in M. tuberculosis 
H37Rv have been classed into four different categories.  The following tables elaborate on this 
classification. 
 
2.3.2.1. Genes predicted to be specifically required for growth on cholesterol 
Griffin et al. (2011) identified genes that are important for the growth of M. tuberculosis on 
cholesterol. Through a deep sequencing-based mapping approach, they identified 96 genes 
predicted to be important for M. tuberculosis growth on cholesterol (Table 2.1).  Independent 
studies also confirmed that the genes identified by Griffin et al. (2011) to be important for M. 
tuberculosis, grow on cholesterol (Van Der Geize et al., 2007; Johnston et al., 2010; Nesbitt et 
al., 2010; Ouellet et al., 2011; Mukhopadhyay et al., 2012; García-Fernández et al., 2013). 
 
Table 2.1. Genes predicted to be specifically required for growth on cholesterol (taken from 
Griffin et al., 2011). 
Gene Location Enzyme 
ppiA Rv0009 iron-regulated peptidyl-prolyl cis-trans isomerase A 
ptbB Rv0153c phosphotyrosine protein phosphatase PTPB (protein-tyrosine-phosphatase) 
(PTPase) 
mmpL11 Rv0202c transmembrane transport protein MmpL11 
fadE5 Rv0244c acyl-CoA dehydrogenase  
mgtE Rv0362 Mg2+ transport transmembrane protein MgtE 
metZ Rv0391 O-succinylhomoserine sulfhydrylase 
mmpL4 Rv0450c transmembrane transport protein MmpL4 
  Rv0485 transcriptional regulatory protein 
  Rv0495c HP 
mkl Rv0655 ribonucleotide ABC transporter ATP-binding protein 
pqqE Rv0693 coenzyme PQQ synthesis protein E 
lldD1 Rv0694 L-lactate dehydrogenase (cytochrome) LldD1 
  Rv0695 HP 
  Rv0696 membrane sugar transferase 
adhB Rv0761c zinc-containing alcohol dehydrogenase NAD dependent ADHB 
  Rv0805 HP 
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Gene Location Enzyme 
  Rv0876c transmembrane protein 
echA9 Rv1071c 3-hydroxyisobutyryl-CoA hydrolase 
  Rv1084 HP 
  Rv1096 glycosyl hydrolase 
  Rv1129c transcriptional regulator protein 
  Rv1130 HP 
gltA1 Rv1131 citrate synthase 
mmpL10 Rv1183 transmembrane transport protein MmpL10 
fadD36 Rv1193 acyl-CoA synthetase 
  Rv1428c HP 
  Rv1432 dehydrogenase 
bcpB Rv1608c peroxidoxin BcpB 
  Rv1626 two-component system transcriptional regulator 
  Rv1627c lipid-transfer protein 
  Rv1798 HP 
  Rv1906c HP 
  Rv1919c HP 
mce3R Rv1963c transcriptional repressor (probably TETR-family) MCE3R 
pks12 Rv2048c polyketide synthase pks12 
  Rv2118c RNA methyltransferase 
  Rv2206 transmembrane protein 
  Rv2239c HP 
eis Rv2416c HP 
tig Rv2462c trigger factor 
  Rv2506 TetR family transcriptional regulator 
  Rv2668 HP 
  Rv2681 HP 
arsA Rv2684 arsenic-transport integral membrane protein ArsA 
sigB Rv2710 RNA polymerase sigma factor SigB 
  Rv2799 HP 
pknI Rv2914c transmembrane serine/threonine-protein kinase I 
mutT1 Rv2985 hydrolase MutT1 
  Rv3050c AsnC family transcriptional regulator 
fadE25 Rv3274c acyl-CoA dehydrogenase FADE25 
gcp Rv3419c putative DNA-binding/iron metalloprotein/AP endonuclease 
  Rv3421c HP 
  Rv3492c CHP MCE associated protein 
  Rv3493c CHP MCE associated protein 
mce4F Rv3494c Mce4 transport system 
mce4E / lprN Rv3495c Mce4 transport system 
mce4D Rv3496c Mce4 transport system 
mce4C Rv3497c Mce4 transport system 
mce4B Rv3498c Mce4 transport system 
mce4A Rv3499c Mce4 transport system 
yrb4B / YrbE4B / 
supB 
Rv3500c possible ABC transporter (Sterol uptake permease subunit) 
yrb4A / YrbE4A / 
supA 
Rv3501c possible ABC transporter (Sterol uptake permease subunit) 
hsd4A Rv3502c 17β-hydroxysteroid dehydrogenase (17β-HSD) 
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Gene Location Enzyme 
fadD19 Rv3515c probable fatty-acid-CoA ligase 
kshA Rv3526 kerosteroid-9α-hydroxylase, oxygenase 
  Rv3531c hypothetical protein 
hsaF Rv3534c probable 4-hydroxy-2-oxovalerate aldolase/4-hydroxy-2-ketovalerate 
aldolase 
hsaE Rv3536c probable hydratase/2-hydroxypentadienoate hydratase 
kstD Rv3537 3-ketosteroid-Δ1-dehydrogenase (Δ1-KSTD) 
ltp2 Rv3540c probable ketoacyl-CoA thiolase 
  Rv3542c CHP/putative enoyl-CoA hydratase 
fadE29 Rv3543c probable acyl-CoA dehydrogenase 
fadE28 Rv3544c probable acyl-CoA dehydrogenase 
cyp125 Rv3545c cytochrome P450 
fadA5 Rv3546 acetoacetyl-CoA thiolase 
  Rv3548c probable short chain dehydrogenase/reductase 
  Rv3549c probable short chain dehydrogenase/reductase 
ipdA Rv3551 ATP-dependent CoA transferase α subunit 
  Rv3553 possible oxidoreductase/2-nitropropane dioxygenase 
  Rv3559c probable oxidoreductase 
fadE30 Rv3560c probable acyl-CoA dehydrogenase 
fadD3 Rv3561 acyl-CoA synthetase (AMP forming) 
fadE32 Rv3563 probable acyl-CoA dehydrogenase 
fadE33 Rv3564 probable acyl-CoA dehydrogenase 
hsaC Rv3568c 3,4-DHSA dioxygenase 
hsaD Rv3569c 4,9-DHSA hydrolase 
hsaA Rv3570c 3-hydroxy-9,10-seconandrost-1,3,5(10)-triene-9,17-dione hydroxylase (3-
HSA hydroxylase, reductase) 
kshB Rv3571 ketosteroid-9α-hydroxylase, reductase 
  Rv3572 HP 
fadE34 Rv3573c probable acyl-CoA dehydrogenase 
  Rv3575c transcriptional regulatory protein LacI-family 
  Rv3779 transmembrane protein alanine and leucine rich 
papA2 Rv3820c polyketide synthase associated protein PapA2 
papA1 Rv3824c polyketide synthase associated protein 
pks2 Rv3825c polyketide synthase PKS2 
sigM Rv3911 RNA polymerase sigma factor SigM 
 
Abbreviations:  3-HAS = 3-hydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione; 3,4-DHSA = 3,4-dihydroxy-
9,10-secoandrosta-1,3,5(10)-triene-9,17-dione; 4,9-DHSA hydrolase = 4,5-9,10-diseco-3-hydroxy-5,9,17-
trioxoandrosta-1(10),2-dien-4-oic acid; 17β-HSD = 17β-hydroxysteroid dehydrogenase; Δ1-KSTD = 3-
ketosteroid-Δ1-dehydrogenase; ABC = ATP-binding cassette; ADH = alcohol dehydrogenase; AMP = adenosine 
monophosphate; AP = apurinic/apyrimidinic; ATP = adenosine triphosphate; Bcp = bacterioferritin comigratory 
protein; CHP = conserved hypothetical protein; CoA = co-enzyme A; DNA = deoxyribonucleic acid; HP = 
© Central University of Technology, Free State
CHAPTER 2: ANNOTATION AND CLASSIFICATION OF GENES/PROTEINS INVOLVED IN CHOLESTEROL DEGRADATION IN 
MYCOBACTERIUM TUBERCULOSIS H37RV 
 
 
39 | P a g e  
 
hypothetical protein; LldD = L-lactate dehydrogenase; MCE = mammalian cell entry; MgtE = Mg2+ transport 
transmembrane protein; MmpL = Mycobacterium membrane protein laboratory; NAD = nicotinamide adenine 
dinucleotide; pks = polyketide synthase; PQQ = pyrrolo-quinoline quinone; PTP/PTPase = phosphotyrosine 
protein phosphatase/protein-tyrosine-phosphatase; RNA = ribonucleic acid; TetR = tetracycline repressor 
 
2.3.2.2. Cholesterol catabolic genes proven to be or predicted to be essential for survival 
of Mycobacterium tuberculosis in macrophage cells and in murine infection 
In the article by Ouellet et al. (2011), some of the cholesterol catabolic genes of M. tuberculosis 
were specified as genes proven to be essential for survival in macrophage cells and in murine 
infection (Table 2.2), or genes predicted to be essential for survival in macrophage cells and in 
murine infection (Table 2.3).  Of the 24 genes listed in Table 2.2 as proven to be essential for 
survival in macrophage cells and in murine infection, 17 genes were predicted to be specifically 
required for growth on cholesterol by Griffin et al. (2011) and in other studies (Van Der Geize 
et al., 2007; Johnston et al., 2010; Nesbitt et al., 2010; Griffin et al., 2011; Van Der Geize et 
al., 2011; García-Fernández, et al., 2013). 
 
Table 2.2. Genes proven to be essential for survival of M. tuberculosis in macrophage cells 
and in murine infection (as listed by Ouellet et al., 2011). 
Gene Location Enzyme 
mce4E / lprN Rv3495c Mce4 transport system 
mce4C Rv3497c Mce4 transport system 
mce4A Rv3499c Mce4 transport system 
yrb4A / YrbE4A / 
supA 
Rv3501c possible ABC transporter (Sterol uptake permease subunit) 
hsd4A Rv3502c 17β-hydroxysteroid dehydrogenase (17β-HSD) 
  Rv3519 CHP 
ltp3 Rv3523 probable ketoacyl-CoA thiolase 
kshA Rv3526 kerosteroid-9α-hydroxylase, oxygenase 
  Rv3527 hypothetical protein (HP) 
hsaF Rv3534c probable 4-hydroxy-2-oxovalerate aldolase/4-hydroxy-2-ketovalerate 
aldolase 
ltp2 Rv3540c probable ketoacyl-CoA thiolase 
  Rv3541c CHP / putative enoyl-CoA hydratase 
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Gene Location Enzyme 
  Rv3542c CHP / putative enoyl-CoA hydratase 
fadE28 Rv3544c probable acyl-CoA dehydrogenase 
cyp125 Rv3545c cytochrome P450 
fadA5 Rv3546 acetoacetyl-CoA thiolase 
ipdA Rv3551 ATP-dependent CoA transferase α subunit 
ipdB Rv3552 ATP-dependent CoA transferase β subunit 
fadA6 Rv3556c acetoacetyl-CoA thiolase 
fadE30 Rv3560c probable acyl-CoA dehydrogenase 
fadE32 Rv3563 probable acyl-CoA dehydrogenase 
hsaC Rv3568c 3,4-DHSA dioxygenase 
kshB Rv3571 ketosteroid-9α-hydroxylase, reductase 
kstR Rv3574 Tet-R transcriptional regulator (repressor) 
 
Abbreviations:  3,4-DHSA = 3,4-dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione; 17β-HSD = 17β-
hydroxysteroid dehydrogenase; ABC = ATP-binding cassette; ATP = adenosine triphosphate; CHP = conserved 
hypothetical protein; CoA = co-enzyme A; HP = hypothetical protein; MCE = mammalian cell entry; Tet-R = 
tetracycline repressor 
 
Table 2.3. Genes predicted to be essential for survival of M. tuberculosis in macrophage cells 
and in murine infection (as listed by Ouellet et al., 2011). 
Gene Location Enzyme 
kstD Rv3537 3-ketosteroid-Δ1-dehydrogenase (Δ1-KSTD) 
fadE28 Rv3544c probable acyl-CoA dehydrogenase 
ipdA Rv3551 ATP-dependent CoA transferase α subunit 
fadA6 Rv3556c acetoacetyl-CoA thiolase 
fadE30 Rv3560c probable acyl-CoA dehydrogenase 
fadE32 Rv3563 probable acyl-CoA dehydrogenase 
hsaD Rv3569c 4,9-DHSA hydrolase 
hsaA Rv3570c 3-hydroxy-9,10-seconandrost-1,3,5(10)-triene-9,17-dione hydroxylase (3-
HSA hydroxylase, reductase) 
 
Abbreviations:  3-HSA = 3-hydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione; 4,9-DHSA = 4,5-9,10-
diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-dien-4-oic acid; Δ1-KSTD = 3-ketosteroid-Δ1-dehydrogenase; 
ATP = adenosine triphosphate; CoA = co-enzyme A 
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Seven of the eight genes listed in Table 2.3 as predicted to be essential for survival in 
macrophage cells and in murine infection are also listed in Table 2.1 and five in Table 2.2  
These eight genes are also noted in other literature (Van Der Geize et al., 2007; Nesbitt et al., 
2010; Griffin et al., 2011; Van Der Geize et al., 2011; García-Fernández, et al., 2013). 
 
2.3.2.3.  Genes/proteins that are up-regulated during growth on cholesterol 
Table 2.4 lists the genes for M. tuberculosis H37Rv that were predicted to be involved in 
cholesterol metabolism according to research conducted by Van Der Geize et al. (2007).  In 
their study, they found that the complete set of 51 genes specifically expressed during growth 
on cholesterol in Rhodococcus jostii are also found in an 82-gene cluster in the M. tuberculosis 
and M. bovis BCG genomes.  To annotate the cholesterol catabolic genes, they compared the 
sequence similarity of the gene products of R. jostii RHA1 and M. tuberculosis H37Rv strains 
and compiled a table with 28 genes annotated for M. tuberculosis H37Rv (Table 1.1).  For the 
purpose of this chapter, the table has been summarised to show only the genes listed for M. 
tuberculosis H37Rv.  Independent studies confirmed the importance of these genes in 
cholesterol degradation by M. tuberculosis (Nesbitt et al., 2010; Griffin et al., 2011; Ouellet et 
al., 2011 and García-Fernández et al., 2013).  Eighteen of the 28 genes in Table 2.4 are also 
noted in Table 2.1 and ten of these relate to the list in Table 2.2, and three to the list in Table 
2.3. 
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Table 2.4. Genes predicted to be involved in cholesterol catabolism compiled from annotation 
of RHA1, H37Rv and BCG genes assigned to cholesterol pathway (Table 1.1) (taken from Van 
Der Geize et al., 2007). 
Gene Location Enzyme 
choD Rv3409c cholesterol oxidase 
mce4F Rv3494c Mce4 transport system 
mce4E / lprN Rv3495c Mce4 transport system 
mce4D Rv3496c Mce4 transport system 
mce4C Rv3497c Mce4 transport system 
mce4B Rv3498c Mce4 transport system 
mce4A Rv3499c Mce4 transport system 
yrb4B / YrbE4B / 
supB 
Rv3500c possible ABC transporter (Sterol uptake permease subunit) 
yrb4A / YrbE4A / 
supA 
Rv3501c possible ABC transporter (Sterol uptake permease subunit) 
hsd4A Rv3502c 17β-hydroxysteroid dehydrogenase (17β-HSD) 
fadE26 Rv3504 probable acyl-CoA dehydrogenase 
fadE27 Rv3505 probable acyl-CoA dehydrogenase 
fadD17 Rv3506 possible fatty-acid-CoA ligase 
fadD19 Rv3515c probable fatty-acid-CoA ligase 
echA19 Rv3516 possible enoyl-CoA hydratase 
ltp4 Rv3522 probable ketoacyl-CoA thiolase 
ltp3 Rv3523 probable ketoacyl-CoA thiolase 
kshA Rv3526 kerosteroid-9α-hydroxylase, oxygenase 
hsaF Rv3534c probable 4-hydroxy-2-oxovalerate aldolase/4-hydroxy-2-ketovalerate 
aldolase 
hsaG Rv3535c probable aldehyde dehydrogenase 
hsaE Rv3536c probable hydratase / 2-hydroxypentadienoate hydratase 
kstD Rv3537 3-ketosteroid-Δ1-dehydrogenase (Δ1-KSTD) 
hsd4B Rv3538 probable enoyl-CoA hydratase 
hsaB Rv3567c 3-hydroxy-9,10-seconandrost-1,3,5(10)-triene-9,17-dione hydroxylase (3-
HSA hydroxylase, reductase) 
hsaC Rv3568c 3,4-DHSA dioxygenase 
hsaD Rv3569c 4,9-DHSA hydrolase 
hsaA Rv3570c 3-hydroxy-9,10-seconandrost-1,3,5(10)-triene-9,17-dione hydroxylase (3-
HSA hydroxylase, reductase) 
kshB Rv3571 ketosteroid-9α-hydroxylase, reductase 
 
Abbreviations:  3-HSA = 3-hydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione; 3,4-DHSA = 3,4-dihydroxy-
9,10-secoandrosta-1,3,5(10)-triene-9,17-dione; 4,9-DHSA hydrolase = 4,5-9,10-diseco-3-hydroxy-5,9,17-
trioxoandrosta-1(10),2-dien-4-oic acid; 17β-HSD = 17β-hydroxysteroid dehydrogenase; Δ1-KSTD = 3-
ketosteroid-Δ1-dehydrogenase; ABC = ATP-binding cassette; CoA = co-enzyme A; MCE = mammalian cell entry  
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2.3.2.4. Genes involved in cholesterol degradation by M. tuberculosis H37Rv, but not 
confirmed or predicted to be essential 
Table 2.5 lists genes that have been noted as being involved in cholesterol catabolism by 
M. tuberculosis H37Rv, but not confirmed or predicted to be essential as per the published data 
(Van Der Geize et al., 2007; Nesbitt et al., 2010; Ouellet et al., 2011; Yang et al., 2011; 
Mukhopadhyay et al., 2012; Driscoll et al., 2010; García-Fernández et al., 2013).  
 
Table 2.5. Genes involved in cholesterol degradation by M. tuberculosis H37Rv but not 
confirmed or predicted as essential, as per published data (Van Der Geize et al., 2007; Nesbitt 
et al., 2010; Ouellet et al., 2011; Yang et al., 2011; Mukhopadhyay et al., 2012; Driscoll et al., 
2010; García-Fernández et al., 2013). 
Gene Location Enzyme 
fadD10 Rv0099 fatty acid-CoA synthase 
fadB2 Rv0468 hydroxybutyryl-CoA dehydrogenase 
  Rv1106c 3β-hydroxysteroid dehydrogenase (3β-HSD) 
mbtN (fadE14) Rv1346 acyl-CoA dehydrogenase  
fadB3 Rv1715 hydroxybutyryl-CoA dehydrogenase 
fadD9 Rv2590 fatty acid-CoA synthase 
fadE22 Rv3061c acyl-CoA dehydrogenase  
fadE24 Rv3139 acyl-CoA dehydrogenase  
fadE23 Rv3140 acyl-CoA dehydrogenase  
fdxD Rv3503c probable ferredoxin 
PE PGRS53 Rv3507 PE PGRS family 
PE PGRS54 Rv3508 PE PGRS family 
ilvX Rv3509c probable acetohydroxy-acid synthase 
  Rv3510c CHP 
PE PGRS55 Rv3511 PE PGRS family 
PE PGRS56 Rv3512 PE PGRS family 
fadD18 Rv3513c possible fatty-acid-CoA ligase 
PE PGRS57 Rv3514 PE PGRS family 
whiB3 Rv3517 conserved hypothetical protein (CHP) / transcription factor 
cyp142 Rv3518c cytochrome P450 
  Rv3520c coenzyme F420-dependent oxidoreductase 
  Rv3521 CHP 
  Rv3524 probable conserved membrane protein 
  Rv3525c possible siderophore binding protein 
  Rv3528c HP 
  Rv3529c CHP 
  Rv3530c possible oxidoreductase 
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Gene Location Enzyme 
PPE61 Rv3532 PPE family 
PPE62 Rv3533c PPE family 
PPE63 Rv3539 PE 
  Rv3547 CHP 
echA20 Rv3550 possible enoyl-CoA hydratase 
fdxB Rv3554 possible electron transfer protein / ferredoxin 
  Rv3555c CHP 
kstR2 Rv3557c Tet-R transcriptional regulator (repressor) 
PPE64 Rv3558 PPE 
fadE31 Rv3562 probable acyl-CoA dehydrogenase 
aspB Rv3565 possible aspartate aminotransferase 
  Rv3566A CHP 
nhoA / nat Rv3566c arylamine N-acetyltransferase 
 
Abbreviations:  3β-HSD = 3β-hydroxysteroid dehydrogenase; CHP = conserved hypothetical protein; CoA = co-
enzyme A; HP = hypothetical protein; PE = protein family with highly conserved Proline-Glutamate residues near 
the start of their encoded proteins; PGRS = polymorphic GC-rich-repetitive sequence; PPE = protein family with 
highly conserved Proline-Proline-Glutamate; Tet-R = tetracycline repressor 
 
2.3.3. Genes/proteins selected for the study 
Based on the above data, 152 genes were selected for determining mycobacterial species’ 
ability to degrade/utilise cholesterol (Table 2.6). 
 
Table 2.6. List of genes/proteins selected for determining mycobacterial species’ ability to 
degrade/utilise cholesterol. 
Gene Location Enzyme 
mce4E / lprN Rv3495ca,c,d Mce4 transport system 
mce4C Rv3497ca,c,d Mce4 transport system 
mce4A Rv3499ca,c,d Mce4 transport system 
yrb4A / YrbE4A / 
supA 
Rv3501ca,c,d possible ABC transporter (Sterol uptake permease subunit) 
hsd4A Rv3502ca,c,d 17β-hydroxysteroid dehydrogenase (17β-HSD) 
kshA Rv3526a,c,d kerosteroid-9α-hydroxylase, oxygenase 
hsaF Rv3534ca,c,d probable 4-hydroxy-2-oxovalerate aldolase / 4-hydroxy-2-
ketovalerate aldolase 
kstD Rv3537b,c,d 3-ketosteroid-Δ1-dehydrogenase (Δ1-KSTD) 
fadE28 Rv3544ca,b,c probable acyl-CoA dehydrogenase 
ipdA Rv3551a,b,c ATP-dependent CoA transferase α subunit 
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Gene Location Enzyme 
fadE30 Rv3560ca,b,c probable acyl-CoA dehydrogenase 
fadE32 Rv3563a,b,c probable acyl-CoA dehydrogenase 
hsaC Rv3568ca,c,d 3,4-DHSA dioxygenase 
hsaD Rv3569cb,c,d 4,9-DHSA hydrolase 
hsaA Rv3570cb,c,d 3-hydroxy-9,10-seconandrost-1,3,5(10)-triene-9,17-dione 
hydroxylase (3-HSA hydroxylase, reductase) 
kshB Rv3571a,c,d ketosteroid-9α-hydroxylase, reductase 
mce4F Rv3494cc,d Mce4 transport system 
mce4D Rv3496cc,d Mce4 transport system 
mce4B Rv3498cc,d Mce4 transport system 
yrb4B / YrbE4B / 
supB 
Rv3500cc,d possible ABC transporter (Sterol uptake permease subunit) 
fadD19 Rv3515cc,d probable fatty-acid-CoA ligase 
ltp3 Rv3523a,d probable ketoacyl-CoA thiolase 
hsaE Rv3536cc,d probable hydratase/2-hydroxypentadienoate hydratase 
ltp2 Rv3540ca,c probable ketoacyl-CoA thiolase 
  Rv3542ca,c CHP / putative enoyl-CoA hydratase 
cyp125 Rv3545ca,c cytochrome P450 
fadA5 Rv3546a,c acetoacetyl-CoA thiolase 
fadA6 Rv3556ca,b acetoacetyl-CoA thiolase 
ppiA Rv0009c iron-regulated peptidyl-prolyl cis-trans isomerase A 
fadD10 Rv0099e fatty acid-CoA synthase 
ptbB Rv0153cc phosphotyrosine protein phosphatase PTPB (protein-tyrosine-
phosphatase) (PTPase) 
mmpL11 Rv0202cc transmembrane transport protein MmpL11 
fadE5 Rv0244cc acyl-CoA dehydrogenase  
mgtE Rv0362c Mg2+ transport transmembrane protein MgtE 
metZ Rv0391c O-succinylhomoserine sulfhydrylase 
mmpL4 Rv0450cc transmembrane transport protein MmpL4 
fadB2 Rv0468e hydroxybutyryl-CoA dehydrogenase 
  Rv0485c transcriptional regulatory protein 
  Rv0495cc HP 
mkl Rv0655c ribonucleotide ABC transporter ATP-binding protein 
pqqE Rv0693c coenzyme PQQ synthesis protein E 
lldD1 Rv0694c L-lactate dehydrogenase (cytochrome) LldD1 
  Rv0695c HP 
  Rv0696c membrane sugar transferase 
adhB Rv0761cc zinc-containing alcohol dehydrogenase NAD dependent ADHB 
  Rv0805c HP 
  Rv0876cc transmembrane protein 
echA9 Rv1071cc 3-hydroxyisobutyryl-CoA hydrolase 
  Rv1084c HP 
  Rv1096c glycosyl hydrolase 
  Rv1106ce 3β-HSD 
  Rv1129cc transcriptional regulator protein 
  Rv1130c HP 
gltA1 Rv1131c citrate synthase 
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Gene Location Enzyme 
mmpL10 Rv1183c transmembrane transport protein MmpL10 
fadD36 Rv1193c acyl-CoA synthetase 
mbtN (fadE14) Rv1346e acyl-CoA dehydrogenase  
  Rv1428cc HP 
  Rv1432c dehydrogenase 
bcpB Rv1608cc peroxidoxin BcpB 
  Rv1626c two-component system transcriptional regulator 
  Rv1627cc lipid-transfer protein 
fadB3 Rv1715e hydroxybutyryl-CoA dehydrogenase 
  Rv1798c HP 
  Rv1906cc HP 
  Rv1919cc HP 
mce3R Rv1963cc transcriptional repressor (probably TETR-family) MCE3R 
pks12 Rv2048cc polyketide synthase pks12 
  Rv2118cc RNA methyltransferase 
  Rv2206c transmembrane protein 
  Rv2239cc HP 
eis Rv2416cc HP 
tig Rv2462cc trigger factor 
  Rv2506c TetR family transcriptional regulator 
fadD9 Rv2590e fatty acid-CoA synthase 
  Rv2668c HP 
  Rv2681c HP 
arsA Rv2684c arsenic-transport integral membrane protein ArsA 
sigB Rv2710c RNA polymerase sigma factor SigB 
  Rv2799c HP 
pknI Rv2914cc transmembrane serine/threonine-protein kinase I 
mutT1 Rv2985c hydrolase MutT1 
  Rv3050cc AsnC family transcriptional regulator 
fadE22 Rv3061ce acyl-CoA dehydrogenase  
fadE24 Rv3139e acyl-CoA dehydrogenase  
fadE23 Rv3140e acyl-CoA dehydrogenase  
fadE25 Rv3274cc acyl-CoA dehydrogenase FADE25 
choD Rv3409cd cholesterol oxidase 
gcp Rv3419cc putative DNA-binding/iron metalloprotein/AP endonuclease 
  Rv3421cc HP 
  Rv3492cc CHP MCE associated protein 
  Rv3493cc CHP MCE associated protein 
fdxD Rv3503ce probable ferredoxin 
fadE26 Rv3504d probable acyl-CoA dehydrogenase 
fadE27 Rv3505d probable acyl-CoA dehydrogenase 
fadD17 Rv3506d possible fatty-acid-CoA ligase 
PE PGRS53 Rv3507e PE PGRS family 
PE PGRS54 Rv3508e PE PGRS family 
ilvX Rv3509ce probable acetohydroxy-acid synthase 
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Gene Location Enzyme 
  Rv3510ce CHP 
PE PGRS55 Rv3511e PE PGRS family 
PE PGRS56 Rv3512e PE PGRS family 
fadD18 Rv3513ce possible fatty-acid-CoA ligase 
PE PGRS57 Rv3514e PE PGRS family 
echA19 Rv3516d possible enoyl-CoA hydratase 
whiB3 Rv3517e conserved hypothetical protein (CHP)/transcription factor 
cyp142 Rv3518ce cytochrome P450 
  Rv3519a CHP 
  Rv3520ce coenzyme F420-dependent oxidoreductase 
  Rv3521e CHP 
ltp4 Rv3522d probable ketoacyl-CoA thiolase 
  Rv3524e probable conserved membrane protein 
  Rv3525ce possible siderophore binding protein 
  Rv3527a hypothetical protein (HP) 
  Rv3528ce HP 
  Rv3529ce CHP 
  Rv3530ce possible oxidoreductase 
  Rv3531cc hypothetical protein 
PPE61 Rv3532e PPE family 
PPE62 Rv3533ce PPE family 
hsaG Rv3535cd probable aldehyde dehydrogenase 
hsd4B Rv3538d probable enoyl-CoA hydratase 
PPE63 Rv3539e PE 
  Rv3541ca CHP/putative enoyl-CoA hydratase 
fadE29 Rv3543cc probable acyl-CoA dehydrogenase 
  Rv3547e CHP 
  Rv3548cc probable short chain dehydrogenase/reductase 
  Rv3549cc probable short chain dehydrogenase/reductase 
echA20 Rv3550e possible enoyl-CoA hydratase 
ipdB Rv3552a ATP-dependent CoA transferase β subunit 
  Rv3553c possible oxidoreductase/2-nitropropane dioxygenase 
fdxB Rv3554e possible electron transfer protein/ferredoxin 
  Rv3555ce CHP 
kstR2 Rv3557ce Tet-R transcriptional regulator (repressor) 
PPE64 Rv3558e PPE 
  Rv3559cc probable oxidoreductase 
fadD3 Rv3561c acyl-CoA synthetase (AMP forming) 
fadE31 Rv3562e probable acyl-CoA dehydrogenase 
fadE33 Rv3564c probable acyl-CoA dehydrogenase 
aspB Rv3565e possible aspartate aminotransferase 
  Rv3566Ae CHP 
nhoA / nat Rv3566ce arylamine N-acetyltransferase 
hsaB Rv3567cd 3-hydroxy-9,10-seconandrost-1,3,5(10)-triene-9,17-dione 
hydroxylase (3-HSA hydroxylase, reductase) 
  Rv3572c HP 
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Gene Location Enzyme 
fadE34 Rv3573cc probable acyl-CoA dehydrogenase 
kstR Rv3574a Tet-R transcriptional regulator (repressor) 
  Rv3575cc transcriptional regulatory protein LacI-family 
  Rv3779c transmembrane protein alanine and leucine rich 
papA2 Rv3820cc polyketide synthase associated protein PapA2 
papA1 Rv3824cc polyketide synthase associated protein 
pks2 Rv3825cc polyketide synthase PKS2 
sigM Rv3911c RNA polymerase sigma factor SigM 
 
Notes: 
a  Genes proven to be essential for survival in macrophage cells and in murine infection. 
b  Genes predicted to be essential for survival in macrophage cells and in murine infection. 
c  Genes predicted to be specifically required for growth on cholesterol. 
d  Genes predicted to be involved in cholesterol catabolism compiled from  annotation of RHA1, H37Rv and BCG 
genes assigned to cholesterol pathway. 
e  Genes involved in cholesterol degradation by M. tuberculosis H37Rv but not confirmed or predicted as essential, 
as per published data. 
Abbreviations:  3-HSA = 3-hydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione; 3,4-DHSA = 3,4-dihydroxy-
9,10-secoandrosta-1,3,5(10)-triene-9,17-dione; 3β-HSD = 3β-hydroxysteroid dehydrogenase; 4,9-DHSA 
hydrolase = 4,5-9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-dien-4-oic acid; 17β-HSD = 17β-
hydroxysteroid dehydrogenase; Δ1-KSTD = 3-ketosteroid-Δ1-dehydrogenase; ABC = ATP-binding cassette; 
ADH = alcohol dehydrogenase; AMP = adenosine monophosphate; AP = apurinic/apyrimidinic; ATP = adenosine 
triphosphate; Bcp = bacterioferritin comigratory protein; CHP = conserved hypothetical protein; CoA = co-
enzyme A; DNA = deoxyribonucleic acid; HP = hypothetical protein; LldD = L-lactate dehydrogenase; MCE = 
mammalian cell entry; MgtE = Mg2+ transport transmembrane protein; MmpL = Mycobacterium membrane 
protein laboratory; NAD = nicotinamide adenine dinucleotide; PE = protein family with highly conserved Proline-
Glutamate residues near the start of their encoded proteins; PGRS = polymorphic GC-rich-repetitive sequence; 
pks = polyketide synthase; PPE = protein family with highly conserved Proline-Proline-Glutamate; PQQ = 
pyrrolo-quinoline quinone; PTP/PTPase = phosphotyrosine protein phosphatase/protein-tyrosine-phosphatase; 
RNA = ribonucleic acid; TetR/TETR = tetracycline repressor. 
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2.4. Conclusion 
In this chapter the cholesterol degradation pathway was annotated, and includes different 
enzymatic reactions and genes/proteins involved at each of the steps..  The genes/proteins 
identified in literature to be possibly, probably or definitely involved in the breakdown of 
cholesterol in M. tuberculosis H37Rv were then classified.  One hundred and fifty-two 
genes/proteins that are possibly, probably or definitely involved in the cholesterol degradation 
pathway were selected for determining the mycobacterial species’ ability to degrade/utilise 
cholesterol.  
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CHAPTER 3 
IN SILICO DETERMATION OF THE CHOLESTEROL DEGRADATION 
ABILITY OF MYCOBACTERIAL SPECIES  
  
3.1. Introduction 
Genes/proteins involved in cholesterol degradation are now considered as novel drug targets 
in the fight against the deadliest human pathogen, M. tuberculosis (Ouellet et al., 2011).  
However, to date, a study analysing the cholesterol degradation capability of different species 
belonging to the genus Mycobacterium has not been reported.  Furthermore, performing wet-
laboratory experiments on a large scale with different mycobacterial species are quite laborious 
and time- and money-consuming.  
Considering the above facts and taking advantage of the genome sequencing of quite a 
number of mycobacterial species, this study is aimed at performing comprehensive in silico 
comparative analysis of the genes/proteins involved in cholesterol degradation of the genus 
Mycobacterium.  Study results are aimed at identifying mycobacterial species capable of using 
cholesterol as a carbon source.  
 
3.2. Methodology 
3.2.1. Species selected for the study 
Ninety-three mycobacterial species belonging to six different categories were used in this study 
(Table 3.1.).  The six categories include Mycobacterium tuberculosis complex (MTBC) (39 
species), Mycobacterium chelonae-abscessus complex (MCAC) (10 species), Mycobacterium 
avium complex (MAC) (15 species), Mycobacteria causing leprosy (MCL) (2 species), 
nontuberculous mycobacteria (NTM) (8 species) and Saprophytes (SAP) (19 species).  The 
criteria for separation of the mycobacterial species into six different groups are based on their 
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characteristic features, including ecological niches, as well as the nature and site of infection 
as described elsewhere (Ventura et al., 2007; Parvez et al., 2016).  Furthermore, taxonomical 
grouping of mycobacterial species is taken into consideration as described elsewhere (Tortoli, 
2012).  Detailed information on species, their categories, and genome database links are listed 
in Table 3.1.  
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3.2.2. Protein domain/function analysis 
In Chapter 2, 152 genes/proteins were identified to be probably, possiblty or definitely involved 
in the cholesterol degradation pathway of M. tuberculosis H37Rv (Table 2.6 in Chapter 2).  It 
is necessary to identify the presence or absence of the above 152 genes/proteins in different 
mycobacterial species in order to determine if these mycobacterial species have the capability 
to degrade cholesterol as a sole carbon and energy source.  The following sections explain the 
procedures followed for protein domain/function analysis. 
 
3.2.2.1. Protein sequences 
The selected 152 proteins’ (Table 2.6 in Chapter 2) sequences were retrieved from the KEGG 
database using the respective gene codes.  
 
3.2.2.2. BLAST analysis 
The protein sequences of 152 M. tuberculosis proteins were copied and pasted into the Basic 
Local Alignment Search Tool (BLAST) in the KEGG database 
(http://www.genome.jp/tools/blast/) for BLAST.  The amino acid sequence was entered in the 
“sequence data” field, then “favorite organism code or category” was selected under the 
“KEGG GENES” button, “Mycobacterium” was entered in the free text field provided and the 
“Compute” link at the top clicked.  Once the BLAST was complete, the “show all result” link 
at the bottom of the output data was selected.  The resulting output was then copied and pasted 
into an Excel program (see description below) to extract the required data (organism code, 
enzyme code, enzyme name, identity and homology (positives)) from all of the BLAST output 
data, which was then tabulated under each organism’s name and code (Supplementary dataset 
1). 
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3.2.2.3. Excel program for extracting KEGG BLAST data 
To extract the required data from the BLAST output data obtained from the KEGG database, 
an Excel program written in an Excel worksheet was used.  The generated program is presented 
below: 
Sheet/tab 1: Original Data 
Cell A2-A80 000:  
Copy the output data from KEGG database into cell A1 to A80 000 (depending on the size of 
the data). 
Cell B2-B80 000: 
=IF(ISNUMBER(SEARCH(">",A2)),"1",IF(ISNUMBER(SEARCH("Identities",A2)),"2",IF(I
SNUMBER(SEARCH("Length",A2)),"3","N"))) 
Determine if the character “>”, the word “Identities” or “Length” is present in the data in 
column A. 
For “>”, return the number “1” (a “1” will populate the next column). 
For “Identities”, return the number “2” (a “2” will populate the next column). 
For “Length”, return the number “3” (a “3” will populate the next column). 
Else, if none of the above is present, return the letter “N” (an “N” will populate the next 
column). 
Cell C2-C80 000: 
=IF(B2="1",IF(B3="3",1,IF(B4="3",2,IF(B5="3",3,IF(B6="3",4,"many")))),"") 
Determine the number of rows the specific record consists of, up to a maximum of four lines.  
If the record is longer than four lines, the word “many” will be displayed, indicating that manual 
investigation and entry are required. 
Cell D2-D80 000: 
=IF(B2="1", A2, "") 
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If valid data to be filtered contains “>” in Column A, then display the data in this row. 
Cell E2:E80 000: 
=IF(B2="2", A2, "") 
If valid data to be filtered contains “Identifies” in Column A, then display the data in this row. 
Cell F2-F80 000: 
=IF(ISNUMBER(SEARCH(">",D2)),LEFT(D2, LEN(D2)-5),D2) 
If this row in Column D includes the character “>”, then it displays the first characters, less 5 
than the length of Column D. 
Cell G2-G80 000: 
=IF(C2=1,F2,IF(C2=2,(F2&""&A3),IF(C2=3,(F2&""&A3&" 
"&A4),IF(C2=4,(F2&""&A3&" "&A4&" "&A5),"")))) 
Combines the data into one cell to include all separate rows with valid data. 
Cell H2 - O80 000: 
Find the position of the first “:”, first “ “, total length, first “(“, first “%”, second “(“, second 
“%” to determine the “Org Code”, “Code”, “Name”, “Identity” and “Positive” for Final Data 
Blanks sheet/tab (Columns O to S). 
Sheet/tab 2: Final Data Blanks 
“Unformatted” column is populated if valid data is present in the corresponding cell in the 
Original Data sheet/tab. 
“Org Code” obtained from Original Data sheet: Column O. 
“Code” obtained from Original Data: Column P. 
“Name” obtained from Original Data: Column Q and multiple spaces filtered. 
“Identity” obtained from Original Data: Column R. 
“Positives” obtained from Original Data: Column S. 
Sheet/tab 3: Final Data 
© Central University of Technology, Free State
CHAPTER 3: IN SILICO DETERMINATION OF THE CHOLESTEROL DEGRADATION ABILITY OF MYCOBACTERIAL SPECIES 
 
62 | P a g e  
 
The data in columns B to F in the “Final Data Blanks” sheet/tab is copied and pasted into the 
“Final Data” sheet/tab and sorted alphabetically according to the first column (Org Code) – 
this just makes the copying into the BLAST sheet easier.  The data was also copied and 
transpose pasted to display it horizontally to make copying easier. 
Validation 
Before using this program, validation was performed with three different datasets and 
continuous checks were carried out throughout the use of the program. 
 
3.2.2.4. Data collection and domain/function analysis 
All the top hit protein sequences in 93 mycobacterial species were collected (Supplementary 
dataset 2) and submitted to NCBI CDD database 
(https://www.ncbi.nlm.nih.gov/Structure/bwrpsb/bwrpsb.cgi).  Based on the NCBI CDD 
results, proteins belonging to the same family/superfamily were identified (Supplementary 
dataset 3). For some proteins no results were obtained at NCBI CDD. Thus, the KEGG database 
was searched for possible functions or domains to determine whether they belonged to the same 
group (Supplementary dataset 1).  
 
3.2.3. Data-processing methodology 
The superfamilies as per the NCBI CDD output were considered to determine whether the 
genes/proteins from the 92 mycobacterial species were a match to those from M. tuberculosis 
H37Rv.  Where no data on superfamilies was available in the NCBI database, a secondary 
review was performed of the KEGG BLAST output data, by looking at the percentage identity, 
percentage homology and the name (thus also the function) of each of the genes/proteins.  
However, the presence or absence of some proteins in different mycobacterial species was 
determined based on the information below:  
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 The Rv3512 gene/protein homolog was not identified in many species in the KEGG 
BLAST output.  This may be due to annotation errors, as M. tuberculosis H37Rv (1998) 
(Mycobacterium code mtu) and M. tuberculosis H37Rv (2012) (Mycobacterium code mtv) 
yielded different results.  Furthermore, this gene is not proven to be essential for cholesterol 
degradation.  Thus, this gene was omitted from the analysis. 
 For Rv1906, more than 40% identity to M. tuberculosis H37Rv was taken as positive 
across all the categories, as the proteins are hypothetical.  From this, the negative species are 
Mycobacterium abscessus ATCC 19977 (mab); Mycobacterium abscessus subsp. bolletii 
50594 (mabb), Mycobacterium abscessus subsp. bolletii GO 06 (mmv), Mycobacterium 
abscessus subsp. bolletii MA 1948 (may), Mycobacterium abscessus subsp. bolletii MC1518 
(mabo), Mycobacterium abscessus subsp. bolletii CCUG 48898 = JCM 15300 (mabl), 
Mycobacterium abscessus subsp. bolletii 103 (maz), Mycobacterium abscessus subsp. 
abscessus MM1513 (mak), Mycobacterium abscessus DJO-44274 (mys), and Mycobacterium 
abscessus 4529 (myc). 
For Rv3566A, more than 40% identity to M. tuberculosis H37Rv was taken as positive 
across all the categories as the proteins are hypothetical. 
For Rv3572, more than 40% identity to M. tuberculosis H37Rv was taken as positive 
across all the categories as the proteins are hypothetical. 
For Rv3527, more than 40% identity to M. tuberculosis H37Rv was taken as positive 
across all the categories as the proteins are hypothetical. 
 The results were tabulated per complex by colour-coding the cells according to the 
following criteria:  green = gene homolog present; black = gene homolog absent. 
The following section provides a detailed discussion of the results. 
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3.3. Results and Discussion 
3.3.1. Determining the cholesterol-degrading ability of 39 MTBC species 
Detailed analysis of 151 gene homologs across 39 MTBC species revealed the absence of the 
following cholesterol-degrading genes (Tables 3.2 and 3.3): 
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Table 3.2. Analysis of 151 gene homologs across 39 MTBC species.  Colour codes: green colour indicates presence of the homolog and black 
colour indicates absence of the homolog. Mycobacterial species codes were listed in Table 3.1. 
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Rv0009                                        
Rv0153c                                        
Rv0202c                                        
Rv0244c                                        
Rv0362                                        
Rv0391                                        
Rv0450c                                        
Rv0485                                        
Rv0495c                                        
Rv0655                                        
Rv0693                                        
Rv0694                                        
Rv0695                                        
Rv0696                                        
Rv0761c                                        
Rv0805                                        
Rv0876c                                        
Rv1071c                                        
Rv1084                                        
Rv1096                                        
Rv1129c                                        
Rv1130                                        
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Organism 
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Rv1131                                        
Rv1183                                        
Rv1193                                        
Rv1428c                                        
Rv1432                                        
Rv1608c                                        
Rv1626                                        
Rv1627c                                        
Rv1798                                        
Rv1906c                                        
Rv1919c                                        
Rv1963c                                        
Rv2048c                                        
Rv2118c                                        
Rv2206                                        
Rv2239c                                        
Rv2416c                                        
Rv2462c                                        
Rv2506                                        
Rv2668                                        
Rv2681                                        
Rv2684                                        
Rv2710                                        
Rv2799                                        
Rv2914c                                        
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Organism 
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Rv2985                                        
Rv3050c                                        
Rv3274c                                        
Rv3409c                                        
Rv3419c                                        
Rv3421c                                        
Rv3492c                                        
Rv3493c                                        
Rv3494c                                        
Rv3495c                                        
Rv3496c                                        
Rv3497c                                        
Rv3498c                                        
Rv3499c                                        
Rv3500c                                        
Rv3501c                                        
Rv3502c                                        
Rv3504                                        
Rv3505                                        
Rv3506                                        
Rv3515c                                        
Rv3516                                        
Rv3522                                        
Rv3523                                        
Rv3526                                        
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Rv3534c                                        
Rv3535c                                        
Rv3536c                                        
Rv3537                                        
Rv3538                                        
Rv3540c                                        
Rv3542c                                        
Rv3543c                                        
Rv3544c                                        
Rv3545c                                        
Rv3546                                        
Rv3548c                                        
Rv3549c                                        
Rv3551                                        
Rv3553                                        
Rv3559c                                        
Rv3560c                                        
Rv3561                                        
Rv3563                                        
Rv3564                                        
Rv3567c                                        
Rv3568c                                        
Rv3569c                                        
Rv3570c                                        
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Rv3573c                                        
Rv3575c                                        
Rv3779                                        
Rv3820c                                        
Rv3824c                                        
Rv3825c                                        
Rv3911                                        
Rv1106c                                        
Rv3503c                                        
Rv3507                                        
Rv3508                                        
Rv3509c                                        
Rv3510c                                        
Rv3511                                        
Rv3513c                                        
Rv3514                                        
Rv3517                                        
Rv3518c                                        
Rv3519                                        
Rv3520c                                        
Rv3521                                        
Rv3524                                        
Rv3525c                                        
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Organism 
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Rv3527                                        
Rv3528c                                        
Rv3529c                                        
Rv3530c                                        
Rv3532                                        
Rv3533c                                        
Rv3539                                        
Rv3541c                                        
Rv3547                                        
Rv3550                                        
Rv3552                                        
Rv3554                                        
Rv3555c                                        
Rv3556c                                        
Rv3557c                                        
Rv3558                                        
Rv3562                                        
Rv3565                                        
Rv3566A                                        
Rv3574                                        
Rv3566c                                        
Rv2590                                        
Rv0099                                        
Rv1346                                        
Rv3061c                                        
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Rv3140                                        
Rv3139                                        
Rv0468                                        
Rv1715                                        
 
 
 
 
 
 
 
 
 
© Central University of Technology, Free State
CHAPTER 3: IN SILICO DETERMINATION OF THE CHOLESTEROL DEGRADATION ABILITY OF MYCOBACTERIAL SPECIES 
 
72 | P a g e  
 
Table 3.3. List of cholesterol-degrading homologs that are not found in MTBC species. 
M. tuberculosis 
Gene/Protein 
Species Code Role 
Rv0153c mti Genes predicted to be specifically required for growth on 
cholesterol 
Rv0485 mti; mtuc; mtuh  Genes predicted to be specifically required for growth on 
cholesterol 
Rv0695 mtuc  Genes predicted to be specifically required for growth on 
cholesterol 
Rv0805 mti; mte; mtl; mtn; mbx  Genes predicted to be specifically required for growth on 
cholesterol 
Rv0876c mti; mtuh Genes predicted to be specifically required for growth on 
cholesterol 
Rv1084 mtg; mtuc; mtuh Genes predicted to be specifically required for growth on 
cholesterol 
Rv1096 mtuh Genes predicted to be specifically required for growth on 
cholesterol 
Rv1129c mtuh Genes predicted to be specifically required for growth on 
cholesterol 
Rv1130 mtuc; mce Genes predicted to be specifically required for growth on 
cholesterol 
Rv1432 mtuc Genes predicted to be specifically required for growth on 
cholesterol 
Rv1919c mte; mtl Genes predicted to be specifically required for growth on 
cholesterol 
Rv2206 mbx Genes predicted to be specifically required for growth on 
cholesterol 
Rv2416c mti; mtuc; mtuh Genes predicted to be specifically required for growth on 
cholesterol 
Rv2681 mti; mtuc; mtue Genes predicted to be specifically required for growth on 
cholesterol 
Rv2799 mtg Genes predicted to be specifically required for growth on 
cholesterol 
Rv3526 mti Genes proven to be essential for survival in macrophage cells 
and in murine infection; 
Genes predicted to be specifically required for growth on 
cholesterol; 
Genes predicted to be involved in cholesterol catabolism 
compiled from annotation of RHA1, H37Rv and BCG genes 
assigned to cholesterol pathway 
Rv3531c mti; mtuh Genes predicted to be specifically required for growth on 
cholesterol 
Rv3536c mtuc Genes predicted to be specifically required for growth on 
cholesterol; 
Genes predicted to be involved in cholesterol catabolism 
compiled from annotation of RHA1, H37Rv and BCG genes 
assigned to cholesterol pathway 
Rv3779 mtuc Genes predicted to be specifically required for growth on 
cholesterol 
Rv3517 mcz Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3521 mtuc Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
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M. tuberculosis 
Gene/Protein 
Species Code Role 
Rv3528c maf; mcz Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3555c mtc Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3566A mtf; mtb; mtk; mtz; 
mte; mtl; mtn; mtj; 
mtuc; mtue; mtul; mbk; 
mbx; mcx; mcz 
Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3566c mbx Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
 
Note: (i) For Rv0495c, homolog proteins were identified based on percentage identity as the NCBI CDD database 
did not assign proteins to a particular superfamily.  The percentage identity was resourced from KEGG and it 
ranged from 100% to 99%. (ii) For Rv0805, homolog proteins in mti (Mycobacterium tuberculosis RGTB423) 
and mbx (Mycobacterium bovis BCG ATCC 35743) were not identified, as NCBI CDD did not yield any results.  
Furthermore, the KEGG database showed only 49% identity compared to other species’ homolog proteins that 
showed 100% identity.  Based on this, it was concluded that mti and mbx do not have Rv0805 homolog(s). (iii) 
For Rv1432 there was no hit data for mtuc (Mycobacterium tuberculosis CAS/NITR204) and KEGG data revealed 
a different dehydrogenase hit.  Thus, it was concluded that the homolog is absent. (iv) Upon review of Rv2416c, 
it was found that the homolog protein sequence for mtuh (Mycobacterium tuberculosis Haarlem/NITR202) is 
truncated and present as 28 amino acids, compared to the other species’ homologs with more than 360 amino 
acids, and therefore it was judged to be absent. 
 
3.3.2. Determining the cholesterol-degrading ability of 10 MCAC species 
Detailed analysis of 151 gene homologs across 10 MCAC species revealed the absence of the 
following cholesterol-degrading genes (Tables 3.4 and 3.5): 
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Table 3.4. Analysis of 151 gene homologs across 10 MCAC species.  Colour codes: green 
colour indicates presence of the homolog and black colour indicates absence of the homolog. 
Mycobacterial species codes were listed in Table 3.1. 
Organism Code 
m
ab
 
m
ab
b
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m
v
 
m
ay
 
m
ab
o
 
m
ab
l 
m
az
 
m
ak
 
m
y
s 
m
y
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Gene/Protein 
Rv0009           
Rv0153c           
Rv0202c           
Rv0244c           
Rv0362           
Rv0391           
Rv0450c           
Rv0485           
Rv0495c           
Rv0655           
Rv0693           
Rv0694           
Rv0695           
Rv0696           
Rv0761c           
Rv0805           
Rv0876c           
Rv1071c           
Rv1084           
Rv1096           
Rv1129c           
Rv1130           
Rv1131           
Rv1183           
Rv1193           
Rv1428c           
Rv1432           
Rv1608c           
Rv1626           
Rv1627c           
Rv1798           
Rv1906c           
Rv1919c           
Rv1963c           
Rv2048c           
Rv2118c           
Rv2206           
Rv2239c           
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Organism Code 
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m
y
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m
y
c 
Gene/Protein 
Rv2416c           
Rv2462c           
Rv2506           
Rv2668           
Rv2681           
Rv2684           
Rv2710           
Rv2799           
Rv2914c           
Rv2985           
Rv3050c           
Rv3274c           
Rv3409c           
Rv3419c           
Rv3421c           
Rv3492c           
Rv3493c           
Rv3494c           
Rv3495c           
Rv3496c           
Rv3497c           
Rv3498c           
Rv3499c           
Rv3500c           
Rv3501c           
Rv3502c           
Rv3504           
Rv3505           
Rv3506           
Rv3515c           
Rv3516           
Rv3522           
Rv3523           
Rv3526           
Rv3531c           
Rv3534c           
Rv3535c           
Rv3536c           
Rv3537           
Rv3538           
Rv3540c           
Rv3542c           
Rv3543c           
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Organism Code 
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m
y
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Gene/Protein 
Rv3544c           
Rv3545c           
Rv3546           
Rv3548c           
Rv3549c           
Rv3551           
Rv3553           
Rv3559c           
Rv3560c           
Rv3561           
Rv3563           
Rv3564           
Rv3567c           
Rv3568c           
Rv3569c           
Rv3570c           
Rv3571           
Rv3572           
Rv3573c           
Rv3575c           
Rv3779           
Rv3820c           
Rv3824c           
Rv3825c           
Rv3911           
Rv1106c           
Rv3503c           
Rv3507           
Rv3508           
Rv3509c           
Rv3510c           
Rv3511           
Rv3513c           
Rv3514           
Rv3517           
Rv3518c           
Rv3519           
Rv3520c           
Rv3521           
Rv3524           
Rv3525c           
Rv3527           
Rv3528c           
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Organism Code 
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m
y
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m
y
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Gene/Protein 
Rv3529c           
Rv3530c           
Rv3532           
Rv3533c           
Rv3539           
Rv3541c           
Rv3547           
Rv3550           
Rv3552           
Rv3554           
Rv3555c           
Rv3556c           
Rv3557c           
Rv3558           
Rv3562           
Rv3565           
Rv3566A           
Rv3574           
Rv3566c           
Rv2590           
Rv0099           
Rv1346           
Rv3061c           
Rv3140           
Rv3139           
Rv0468           
Rv1715           
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Table 3.5. List of cholesterol-degrading homologs that are not found in MCAC species. 
M. tuberculosis 
Gene/Protein 
Species Code Role 
Rv0876c mab; mabb; mmv; mabl Genes predicted to be specifically required for growth on 
cholesterol 
Rv1906c mab; mabb; may; 
mabo; mabl; maz; mak 
Genes predicted to be specifically required for growth on 
cholesterol 
Rv2684 mab; mabb; mmv; may; 
mabo; mabl; maz; mak; 
mys; myc 
Genes predicted to be specifically required for growth on 
cholesterol 
Rv3575c mabb; mmv; mabl; 
mak; mys; myc 
Genes predicted to be specifically required for growth on 
cholesterol 
Rv3507 mab; mabb; mmv; may; 
mabo; mabl; maz; mak; 
mys; myc 
Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3508 mab; mabb; mmv; may; 
mabo; mabl; maz; mak; 
mys; myc 
Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3511 mab; mabb; mmv; may; 
mabo; mabl; maz; mak; 
mys; myc 
Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3514 mab; mabb; mmv; may; 
mabo; mabl; maz; mak; 
mys; myc 
Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3517 mabl Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3519 mab; mabb; mmv; may; 
mabo; mabl; maz; mak; 
mys; myc 
Genes proven to be essential for survival in macrophage cells 
and in murine infection 
Rv3524 mab; mabb; mmv; may; 
mabo; mabl; maz; mak; 
mys; myc 
Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3528c mab; mabb; mmv; may; 
mabo; mabl; maz; mak; 
mys; myc 
Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3566A mab; mabb; mmv; may; 
mabo; mabl; maz; mak; 
mys; myc 
Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
 
Note: As reported earlier, with review of Rv1906, more than 40% identity to M. tuberculosis H37Rv was taken 
as positive across all the categories, as the proteins are hypothetical.  From this, 10 negative species were identified 
– all from the MCAC category:  Mycobacterium abscessus ATCC 19977 (mab); Mycobacterium abscessus subsp. 
bolletii 50594 (mabb), Mycobacterium abscessus subsp. bolletii GO 06 (mmv), Mycobacterium abscessus subsp. 
bolletii MA 1948 (may), Mycobacterium abscessus subsp. bolletii MC1518 (mabo), Mycobacterium abscessus 
subsp. bolletii CCUG 48898 = JCM 15300 (mabl), Mycobacterium abscessus subsp. bolletii 103 (maz), 
Mycobacterium abscessus subsp. abcessus MM1513 (mak), Mycobacterium abscessus DJO-44274 (mys), and 
Mycobacterium abscessus 4529 (myc). 
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3.3.3. Determining the cholesterol-degrading ability of 15 MAC species 
Detailed analysis of 151 gene homologs across 15 MAC species revealed the absence of the 
following cholesterol-degrading genes (Tables 3.6 and 3.7): 
 
Table 3.6. Analysis of 151 gene homologs across 15 MAC species.  Colour codes: green colour 
indicates presence of the homolog and black colour indicates absence of the homolog. 
Mycobacterial species codes were listed in Table 3.1. 
Organism Code 
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Gene/Protein 
Rv0009                
Rv0153c                
Rv0202c                
Rv0244c                
Rv0362                
Rv0391                
Rv0450c                
Rv0485                
Rv0495c                
Rv0655                
Rv0693                
Rv0694                
Rv0695                
Rv0696                
Rv0761c                
Rv0805                
Rv0876c                
Rv1071c                
Rv1084                
Rv1096                
Rv1129c                
Rv1130                
Rv1131                
Rv1183                
Rv1193                
Rv1428c                
Rv1432                
Rv1608c                
Rv1626                
Rv1627c                
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Organism Code 
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Rv1798                
Rv1906c                
Rv1919c                
Rv1963c                
Rv2048c                
Rv2118c                
Rv2206                
Rv2239c                
Rv2416c                
Rv2462c                
Rv2506                
Rv2668                
Rv2681                
Rv2684                
Rv2710                
Rv2799                
Rv2914c                
Rv2985                
Rv3050c                
Rv3274c                
Rv3409c                
Rv3419c                
Rv3421c                
Rv3492c                
Rv3493c                
Rv3494c                
Rv3495c                
Rv3496c                
Rv3497c                
Rv3498c                
Rv3499c                
Rv3500c                
Rv3501c                
Rv3502c                
Rv3504                
Rv3505                
Rv3506                
Rv3515c                
Rv3516                
Rv3522                
Rv3523                
Rv3526                
Rv3531c                
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Organism Code 
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Rv3534c                
Rv3535c                
Rv3536c                
Rv3537                
Rv3538                
Rv3540c                
Rv3542c                
Rv3543c                
Rv3544c                
Rv3545c                
Rv3546                
Rv3548c                
Rv3549c                
Rv3551                
Rv3553                
Rv3559c                
Rv3560c                
Rv3561                
Rv3563                
Rv3564                
Rv3567c                
Rv3568c                
Rv3569c                
Rv3570c                
Rv3571                
Rv3572                
Rv3573c                
Rv3575c                
Rv3779                
Rv3820c                
Rv3824c                
Rv3825c                
Rv3911                
Rv1106c                
Rv3503c                
Rv3507                
Rv3508                
Rv3509c                
Rv3510c                
Rv3511                
Rv3513c                
Rv3514                
Rv3517                
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Organism Code 
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Rv3518c                
Rv3519                
Rv3520c                
Rv3521                
Rv3524                
Rv3525c                
Rv3527                
Rv3528c                
Rv3529c                
Rv3530c                
Rv3532                
Rv3533c                
Rv3539                
Rv3541c                
Rv3547                
Rv3550                
Rv3552                
Rv3554                
Rv3555c                
Rv3556c                
Rv3557c                
Rv3558                
Rv3562                
Rv3565                
Rv3566A                
Rv3574                
Rv3566c                
Rv2590                
Rv0099                
Rv1346                
Rv3061c                
Rv3140                
Rv3139                
Rv0468                
Rv1715                
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Table 3.7. List of cholesterol-degrading homologs that are not found in MAC species. 
M. tuberculosis 
Gene/Protein 
Species Code Role 
Rv0153c mao; mavi; mavd Genes predicted to be specifically required for growth on 
cholesterol 
Rv1084 mavi Genes predicted to be specifically required for growth on 
cholesterol 
Rv3779 mav Genes predicted to be specifically required for growth on 
cholesterol 
Rv3519 mit Genes proven to be essential for survival in macrophage cells 
and in murine infection 
Rv3528c mpa; mao; mavi; mavu; 
mav; mavr; mavd; 
mava; mit; mir; mia; 
mie; mid; myo; mmm 
Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3566A mpa; mao; mavi; mavu; 
mav; mavr; mavd; 
mava; mit; mir; mia; 
mie; mid; myo; mmm 
Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
 
 
3.3.4. Determining the cholesterol-degrading ability of 2 MCL species 
Detailed analysis of 151 gene homologs across 2 MCL species revealed the absence of the 
following cholesterol-degrading genes (Tables 3.8 and 3.9): 
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Table 3.8. Analysis of 151 gene homologs across 2 MCL species.  Colour codes: green colour 
indicates presence of the homolog and black colour indicates absence of the homolog. 
Mycobacterial species codes were listed in Table 3.1. 
Organism Code 
m
le
 
m
lb
 
Gene/Protein 
Rv0009   
Rv0153c   
Rv0202c   
Rv0244c   
Rv0362   
Rv0391   
Rv0450c   
Rv0485   
Rv0495c   
Rv0655   
Rv0693   
Rv0694   
Rv0695   
Rv0696   
Rv0761c   
Rv0805   
Rv0876c   
Rv1071c   
Rv1084   
Rv1096   
Rv1129c   
Rv1130   
Rv1131   
Rv1183   
Rv1193   
Rv1428c   
Rv1432   
Rv1608c   
Rv1626   
Rv1627c   
Rv1798   
Rv1906c   
Rv1919c   
Rv1963c   
Rv2048c   
Rv2118c   
Rv2206   
Rv2239c   
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Organism Code 
m
le
 
m
lb
 
Gene/Protein 
Rv2416c   
Rv2462c   
Rv2506   
Rv2668   
Rv2681   
Rv2684   
Rv2710   
Rv2799   
Rv2914c   
Rv2985   
Rv3050c   
Rv3274c   
Rv3409c   
Rv3419c   
Rv3421c   
Rv3492c   
Rv3493c   
Rv3494c   
Rv3495c   
Rv3496c   
Rv3497c   
Rv3498c   
Rv3499c   
Rv3500c   
Rv3501c   
Rv3502c   
Rv3504   
Rv3505   
Rv3506   
Rv3515c   
Rv3516   
Rv3522   
Rv3523   
Rv3526   
Rv3531c   
Rv3534c   
Rv3535c   
Rv3536c   
Rv3537   
Rv3538   
Rv3540c   
Rv3542c   
Rv3543c   
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Organism Code 
m
le
 
m
lb
 
Gene/Protein 
Rv3544c   
Rv3545c   
Rv3546   
Rv3548c   
Rv3549c   
Rv3551   
Rv3553   
Rv3559c   
Rv3560c   
Rv3561   
Rv3563   
Rv3564   
Rv3567c   
Rv3568c   
Rv3569c   
Rv3570c   
Rv3571   
Rv3572   
Rv3573c   
Rv3575c   
Rv3779   
Rv3820c   
Rv3824c   
Rv3825c   
Rv3911   
Rv1106c   
Rv3503c   
Rv3507   
Rv3508   
Rv3509c   
Rv3510c   
Rv3511   
Rv3513c   
Rv3514   
Rv3517   
Rv3518c   
Rv3519   
Rv3520c   
Rv3521   
Rv3524   
Rv3525c   
Rv3527   
Rv3528c   
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Organism Code 
m
le
 
m
lb
 
Gene/Protein 
Rv3529c   
Rv3530c   
Rv3532   
Rv3533c   
Rv3539   
Rv3541c   
Rv3547   
Rv3550   
Rv3552   
Rv3554   
Rv3555c   
Rv3556c   
Rv3557c   
Rv3558   
Rv3562   
Rv3565   
Rv3566A   
Rv3574   
Rv3566c   
Rv2590   
Rv0099   
Rv1346   
Rv3061c   
Rv3140   
Rv3139   
Rv0468   
Rv1715   
 
 
 
 
 
 
 
 
 
© Central University of Technology, Free State
CHAPTER 3: IN SILICO DETERMINATION OF THE CHOLESTEROL DEGRADATION ABILITY OF MYCOBACTERIAL SPECIES 
 
88 | P a g e  
 
Table 3.9. List of cholesterol-degrading homologs that are not found in MCL species. 
M. tuberculosis 
Gene/Protein 
Species Code Role 
Rv0153c mle; mlb Genes predicted to be specifically required for growth on 
cholesterol 
Rv0485 mle; mlb Genes predicted to be specifically required for growth on 
cholesterol 
Rv0693 mle; mlb Genes predicted to be specifically required for growth on 
cholesterol 
Rv0695 mle; mlb Genes predicted to be specifically required for growth on 
cholesterol 
Rv1084 mle; mlb Genes predicted to be specifically required for growth on 
cholesterol 
Rv1129c mle; mlb Genes predicted to be specifically required for growth on 
cholesterol 
Rv1130 mle; mlb Genes predicted to be specifically required for growth on 
cholesterol 
Rv2416c mle; mlb Genes predicted to be specifically required for growth on 
cholesterol 
Rv2668 mle; mlb Genes predicted to be specifically required for growth on 
cholesterol 
Rv2799 mle; mlb Genes predicted to be specifically required for growth on 
cholesterol 
Rv3492c mle; mlb Genes predicted to be specifically required for growth on 
cholesterol 
Rv3493c mle; mlb Genes predicted to be specifically required for growth on 
cholesterol 
Rv3523 mle; mlb Genes proven to be essential for survival in macrophage cells 
and in murine infection; 
Genes predicted to be involved in cholesterol catabolism 
compiled from annotation of RHA1, H37Rv and BCG genes 
assigned to cholesterol pathway 
Rv3526 mle; mlb Genes proven to be essential for survival in macrophage cells 
and in murine infection; 
Genes predicted to be specifically required for growth on 
cholesterol; 
Genes predicted to be involved in cholesterol catabolism 
compiled from annotation of RHA1, H37Rv and BCG genes 
assigned to cholesterol pathway 
Rv3531c mle; mlb Genes predicted to be specifically required for growth on 
cholesterol 
Rv3535c mle; mlb Genes predicted to be involved in cholesterol catabolism 
compiled from annotation of RHA1, H37Rv and BCG genes 
assigned to cholesterol pathway 
Rv3536c mle; mlb Genes predicted to be specifically required for growth on 
cholesterol; 
Genes predicted to be involved in cholesterol catabolism 
compiled from annotation of RHA1, H37Rv and BCG genes 
assigned to cholesterol pathway 
Rv3540c mle; mlb Genes proven to be essential for survival in macrophage cells 
and in murine infection; 
Genes predicted to be specifically required for growth on 
cholesterol 
Rv3551 mle; mlb Genes proven to be essential for survival in macrophage cells 
and in murine infection; 
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M. tuberculosis 
Gene/Protein 
Species Code Role 
Genes predicted to be essential for survival in macrophage 
cells and in murine infection; 
Genes predicted to be specifically required for growth on 
cholesterol 
Rv3553 mle; mlb Genes predicted to be specifically required for growth on 
cholesterol 
Rv3568c mle; mlb Genes proven to be essential for survival in macrophage cells 
and in murine infection; 
Genes predicted to be specifically required for growth on 
cholesterol; 
Genes predicted to be involved in cholesterol catabolism 
compiled from annotation of RHA1, H37Rv and BCG genes 
assigned to cholesterol pathway 
Rv3571 mle; mlb Genes proven to be essential for survival in macrophage cells 
and in murine infection; 
Genes predicted to be specifically required for growth on 
cholesterol; 
Genes predicted to be involved in cholesterol catabolism 
compiled from annotation of RHA1, H37Rv and BCG genes 
assigned to cholesterol pathway 
Rv3503c mle; mlb Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3510c mle; mlb Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3517 mle; mlb Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3519 mle; mlb Genes proven to be essential for survival in macrophage cells 
and in murine infection 
Rv3521 mle; mlb Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3524 mle; mlb Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3527 mle; mlb Genes proven to be essential for survival in macrophage cells 
and in murine infection 
Rv3528c mle; mlb Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3529c mle; mlb Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3552 mle; mlb Genes proven to be essential for survival in macrophage cells 
and in murine infection 
Rv3554 mle; mlb Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3555c mle; mlb Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3566A mle; mlb Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
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M. tuberculosis 
Gene/Protein 
Species Code Role 
Rv3566c mle; mlb Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
 
 
The results for Mycobacterium leprae TN (mle) and Mycobacterium leprae Br4923 
(mlb) are consistent with research done over the years, confirming that species from the MCL 
category lack the genes/proteins necessary for being able to break down cholesterol.  
Sequencing of the M. leprae genome has revealed that, compared to the M. tuberculosis H37Rv 
genome that can potentially encode 3 924 genes (Cole et al., 1998), the M. leprae genome 
encodes only 1 604 proteins and contains 1 116 pseudogenes (Cole et al., 2001).  Research on 
ChoD of M. tuberculosis showed that although 50% of the M. leprae genome contains 
truncated genes, the ortholog ML0389 is complete, but some other sterol catabolic genes in M. 
leprae are encoded by pseudogenes (Brzostek et al., 2007). 
Laboratory research done by Marques et al. (2015) generated results confirming the in silico 
prediction that M. leprae is unable to use cholesterol in central carbon metabolism and energy 
production.  
 Results from this study further confirm that because of the lack of quite a large number 
of cholesterol-degrading genes (Table 3.8 and 3.9), MCL species are unable to use cholesterol 
as a carbon and energy source. 
 
3.3.5. Determining the cholesterol-degrading ability of 8 NTM species 
Detailed analysis of 151 gene homologs across 8 NTM species revealed the absence of the 
following cholesterol-degrading genes (Tables 3.10 and 3.11): 
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Table 3.10. Analysis of 151 gene homologs across 8 NTM species.  Colour codes: green colour 
indicates presence of the homolog and black colour indicates absence of the homolog. 
Mycobacterial species codes were listed in Table 3.1. 
Organism Code 
m
u
l 
m
jd
 
m
m
i 
m
li
 
m
k
n
 
m
k
s 
m
k
i 
m
h
ad
 
Gene/Protein 
Rv0009         
Rv0153c         
Rv0202c         
Rv0244c         
Rv0362         
Rv0391         
Rv0450c         
Rv0485         
Rv0495c         
Rv0655         
Rv0693         
Rv0694         
Rv0695         
Rv0696         
Rv0761c         
Rv0805         
Rv0876c         
Rv1071c         
Rv1084         
Rv1096         
Rv1129c         
Rv1130         
Rv1131         
Rv1183         
Rv1193         
Rv1428c         
Rv1432         
Rv1608c         
Rv1626         
Rv1627c         
Rv1798         
Rv1906c         
Rv1919c         
Rv1963c         
Rv2048c         
Rv2118c         
Rv2206         
Rv2239c         
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Organism Code 
m
u
l 
m
jd
 
m
m
i 
m
li
 
m
k
n
 
m
k
s 
m
k
i 
m
h
ad
 
Gene/Protein 
Rv2416c         
Rv2462c         
Rv2506         
Rv2668         
Rv2681         
Rv2684         
Rv2710         
Rv2799         
Rv2914c         
Rv2985         
Rv3050c         
Rv3274c         
Rv3409c         
Rv3419c         
Rv3421c         
Rv3492c         
Rv3493c         
Rv3494c         
Rv3495c         
Rv3496c         
Rv3497c         
Rv3498c         
Rv3499c         
Rv3500c         
Rv3501c         
Rv3502c         
Rv3504         
Rv3505         
Rv3506         
Rv3515c         
Rv3516         
Rv3522         
Rv3523         
Rv3526         
Rv3531c         
Rv3534c         
Rv3535c         
Rv3536c         
Rv3537         
Rv3538         
Rv3540c         
Rv3542c         
Rv3543c         
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Organism Code 
m
u
l 
m
jd
 
m
m
i 
m
li
 
m
k
n
 
m
k
s 
m
k
i 
m
h
ad
 
Gene/Protein 
Rv3544c         
Rv3545c         
Rv3546         
Rv3548c         
Rv3549c         
Rv3551         
Rv3553         
Rv3559c         
Rv3560c         
Rv3561         
Rv3563         
Rv3564         
Rv3567c         
Rv3568c         
Rv3569c         
Rv3570c         
Rv3571         
Rv3572         
Rv3573c         
Rv3575c         
Rv3779         
Rv3820c         
Rv3824c         
Rv3825c         
Rv3911         
Rv1106c         
Rv3503c         
Rv3507         
Rv3508         
Rv3509c         
Rv3510c         
Rv3511         
Rv3513c         
Rv3514         
Rv3517         
Rv3518c         
Rv3519         
Rv3520c         
Rv3521         
Rv3524         
Rv3525c         
Rv3527         
Rv3528c         
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Organism Code 
m
u
l 
m
jd
 
m
m
i 
m
li
 
m
k
n
 
m
k
s 
m
k
i 
m
h
ad
 
Gene/Protein 
Rv3529c         
Rv3530c         
Rv3532         
Rv3533c         
Rv3539         
Rv3541c         
Rv3547         
Rv3550         
Rv3552         
Rv3554         
Rv3555c         
Rv3556c         
Rv3557c         
Rv3558         
Rv3562         
Rv3565         
Rv3566A         
Rv3574         
Rv3566c         
Rv2590         
Rv0099         
Rv1346         
Rv3061c         
Rv3140         
Rv3139         
Rv0468         
Rv1715         
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Table 3.11. List of cholesterol-degrading homologs that are not found in NTM species. 
M. tuberculosis 
Gene/Protein 
Species Code Role 
Rv1130 mhad Genes predicted to be specifically required for growth on 
cholesterol 
Rv2416c mul Genes predicted to be specifically required for growth on 
cholesterol 
Rv2462c mks; mki Genes predicted to be specifically required for growth on 
cholesterol 
Rv3534c mhad Genes proven to be essential for survival in macrophage cells 
and in murine infection 
Genes predicted to be specifically required for growth on 
cholesterol 
Genes predicted to be involved in cholesterol catabolism 
compiled from annotation of RHA1, H37Rv and BCG genes 
assigned to cholesterol pathway 
Rv3575c mjd Genes predicted to be specifically required for growth on 
cholesterol 
Rv3517 mul Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3528c mul; mjd; mmi; mli; 
mkn; mks; mki; mhad 
Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3566A mul; mjd; mmi; mli; 
mkn; mks; mki; mhad 
Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
 
 
3.3.6. Determining the cholesterol-degrading ability of 19 SAP species 
Detailed analysis of 151 gene homologs across 19 SAP species revealed the absence of the 
following cholesterol-degrading genes (Tables 3.12 and 3.13): 
 
 
 
 
 
 
© Central University of Technology, Free State
CHAPTER 3: IN SILICO DETERMINATION OF THE CHOLESTEROL DEGRADATION ABILITY OF MYCOBACTERIAL SPECIES 
 
96 | P a g e  
 
Table 3.12. Analysis of 151 gene homologs across 19 SAP species.  Colour codes: green colour 
indicates presence of the homolog and black colour indicates absence of the homolog. 
Mycobacterial species codes were listed in Table 3.1. 
Organism Code 
m
sm
 
m
sg
 
m
sb
 
m
sn
 
m
sh
 
m
sa
 
m
v
a 
m
g
i 
m
sp
 
m
m
c 
m
k
m
 
m
jl
 
m
rh
 
m
cb
 
m
n
e 
m
y
v
 
m
y
e 
m
g
o
 
m
ft
 
Gene/Protein 
Rv0009                    
Rv0153c                    
Rv0202c                    
Rv0244c                    
Rv0362                    
Rv0391                    
Rv0450c                    
Rv0485                    
Rv0495c                    
Rv0655                    
Rv0693                    
Rv0694                    
Rv0695                    
Rv0696                    
Rv0761c                    
Rv0805                    
Rv0876c                    
Rv1071c                    
Rv1084                    
Rv1096                    
Rv1129c                    
Rv1130                    
Rv1131                    
Rv1183                    
Rv1193                    
Rv1428c                    
Rv1432                    
Rv1608c                    
Rv1626                    
Rv1627c                    
Rv1798                    
Rv1906c                    
Rv1919c                    
Rv1963c                    
Rv2048c                    
Rv2118c                    
Rv2206                    
Rv2239c                    
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Organism Code 
m
sm
 
m
sg
 
m
sb
 
m
sn
 
m
sh
 
m
sa
 
m
v
a 
m
g
i 
m
sp
 
m
m
c 
m
k
m
 
m
jl
 
m
rh
 
m
cb
 
m
n
e 
m
y
v
 
m
y
e 
m
g
o
 
m
ft
 
Gene/Protein 
Rv2416c                    
Rv2462c                    
Rv2506                    
Rv2668                    
Rv2681                    
Rv2684                    
Rv2710                    
Rv2799                    
Rv2914c                    
Rv2985                    
Rv3050c                    
Rv3274c                    
Rv3409c                    
Rv3419c                    
Rv3421c                    
Rv3492c                    
Rv3493c                    
Rv3494c                    
Rv3495c                    
Rv3496c                    
Rv3497c                    
Rv3498c                    
Rv3499c                    
Rv3500c                    
Rv3501c                    
Rv3502c                    
Rv3504                    
Rv3505                    
Rv3506                    
Rv3515c                    
Rv3516                    
Rv3522                    
Rv3523                    
Rv3526                    
Rv3531c                    
Rv3534c                    
Rv3535c                    
Rv3536c                    
Rv3537                    
Rv3538                    
Rv3540c                    
Rv3542c                    
Rv3543c                    
Rv3544c                    
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Organism Code 
m
sm
 
m
sg
 
m
sb
 
m
sn
 
m
sh
 
m
sa
 
m
v
a 
m
g
i 
m
sp
 
m
m
c 
m
k
m
 
m
jl
 
m
rh
 
m
cb
 
m
n
e 
m
y
v
 
m
y
e 
m
g
o
 
m
ft
 
Gene/Protein 
Rv3545c                    
Rv3546                    
Rv3548c                    
Rv3549c                    
Rv3551                    
Rv3553                    
Rv3559c                    
Rv3560c                    
Rv3561                    
Rv3563                    
Rv3564                    
Rv3567c                    
Rv3568c                    
Rv3569c                    
Rv3570c                    
Rv3571                    
Rv3572                    
Rv3573c                    
Rv3575c                    
Rv3779                    
Rv3820c                    
Rv3824c                    
Rv3825c                    
Rv3911                    
Rv1106c                    
Rv3503c                    
Rv3507                    
Rv3508                    
Rv3509c                    
Rv3510c                    
Rv3511                    
Rv3513c                    
Rv3514                    
Rv3517                    
Rv3518c                    
Rv3519                    
Rv3520c                    
Rv3521                    
Rv3524                    
Rv3525c                    
Rv3527                    
Rv3528c                    
Rv3529c                    
Rv3530c                    
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Organism Code 
m
sm
 
m
sg
 
m
sb
 
m
sn
 
m
sh
 
m
sa
 
m
v
a 
m
g
i 
m
sp
 
m
m
c 
m
k
m
 
m
jl
 
m
rh
 
m
cb
 
m
n
e 
m
y
v
 
m
y
e 
m
g
o
 
m
ft
 
Gene/Protein 
Rv3532                    
Rv3533c                    
Rv3539                    
Rv3541c                    
Rv3547                    
Rv3550                    
Rv3552                    
Rv3554                    
Rv3555c                    
Rv3556c                    
Rv3557c                    
Rv3558                    
Rv3562                    
Rv3565                    
Rv3566A                    
Rv3574                    
Rv3566c                    
Rv2590                    
Rv0099                    
Rv1346                    
Rv3061c                    
Rv3140                    
Rv3139                    
Rv0468                    
Rv1715                    
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Table 3.13. List of cholesterol-degrading homologs that are not found in SAP species. 
M. tuberculosis 
Gene/Protein 
Species Code Role 
Rv0805 msm; msg; msb; msn; 
msh; mva; mgi; msp; 
mmc; mkm; mjl; mrh; 
mne; myv; mgo 
Genes predicted to be specifically required for growth on 
cholesterol 
Rv0876c mye; mgo Genes predicted to be specifically required for growth on 
cholesterol 
Rv1084 msp Genes predicted to be specifically required for growth on 
cholesterol 
Rv1130 msa; mva; mgi; msp; 
mmc; mkm; mjl; mrh; 
mcb; mye 
Genes predicted to be specifically required for growth on 
cholesterol 
Rv1919c msp Genes predicted to be specifically required for growth on 
cholesterol 
Rv2416c mcb; mye Genes predicted to be specifically required for growth on 
cholesterol 
Rv3492c msp Genes predicted to be specifically required for growth on 
cholesterol 
Rv3493c msn Genes predicted to be specifically required for growth on 
cholesterol 
Rv3572 msm; msg; msb; msn; 
msh; mva; mgi; msp; 
mmc; mkm; mjl; mrh; 
mne; myv; mgo; mft 
Genes predicted to be specifically required for growth on 
cholesterol 
Rv3779 msm; msg; msb; msn; 
msh; mva; mgi; msp; 
mmc; mkm; mjl; mrh; 
mne 
Genes predicted to be specifically required for growth on 
cholesterol 
Rv3507 msm; msg; msb; msn; 
msh; msa; mva; mgi; 
msp; mmc; mkm; mjl; 
mrh; mcb; mne; myv; 
mye; mgo; mft 
Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3508 msm; msg; msb; msn; 
msh; msa; mva; mgi; 
msp; mmc; mkm; mjl; 
mrh; mcb; mne; myv; 
mye; mgo; mft 
Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3511 msm; msg; msb; msn; 
msh; msa; mva; msp; 
mmc; mkm; mjl; mcb; 
mne; myv; mye; mgo; 
mft 
Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3514 msm; msg; msb; msn; 
msh; msa; mva; mgi; 
msp; mmc; mkm; mjl; 
mrh; mcb; mne; myv; 
mgo; mft 
Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3517 msa; mva; mne; mye Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3528c msm; msg; msb; msn; 
msh; msa; mva; mgi; 
msp; mmc; mkm; mjl; 
Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
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M. tuberculosis 
Gene/Protein 
Species Code Role 
mrh; mcb; mne; myv; 
mye; mgo; mft 
Rv3566A msm; msg; msb; msn; 
msh; mva; mgi; msp; 
mmc; mkm; mjl; mrh; 
mcb; mne; mye; mgo 
Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
Rv3566c mcb; mye Genes involved in cholesterol degradation by M. tuberculosis 
H37Rv but not confirmed or predicted as essential, as per 
published data 
 
 Based on the above results, a detailed analysis of the presence or absence of 151 
homologs of M. tuberculosis H37Rv in 92 mycobacterial species and the species’ ability to 
degrade cholesterol is shown in Table 3.14. 
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Organism 
Code 
Species 
Absent H37Rv Homologs Relating to Cholesterol Catabolism 
Ability to 
Degrade 
Cholesterol 
Proven to be 
Essential 
Predicted to be 
Essential or 
Specifically 
Required 
Predicted to be 
Involved 
Involved but 
not Proven or 
Predicted to be 
Essential 
mto Mycobacterium tuberculosis CTRI-2         Positive 
mtd Mycobacterium tuberculosis UT205         Positive 
mtn Mycobacterium tuberculosis Erdman = ATCC 35801   Rv0805   Rv3566A Negative 
mtj Mycobacterium tuberculosis Beijing/NITR203       Rv3566A Positive 
mtub Mycobacterium tuberculosis 7199-99         Positive 
mtuc Mycobacterium tuberculosis CAS/NITR204   
Rv0485 
Rv0695 
Rv1084 
Rv1130 
Rv1432 
Rv2416c 
Rv2681 
Rv3536c 
Rv3779 
Rv3536c 
Rv3521 
Rv3566A 
Negative 
mtue Mycobacterium tuberculosis EAI5/NITR206   Rv2681   Rv3566A Negative 
mtx Mycobacterium tuberculosis EAI5         Positive 
mtuh Mycobacterium tuberculosis Haarlem/NITR202   
Rv0485 
Rv0876c 
Rv1084 
Rv1096 
Rv1129c 
Rv2416c 
Rv3531c 
    Negative 
mtul Mycobacterium tuberculosis Haarlem       Rv3566A Positive 
mtut Mycobacterium tuberculosis BT1         Positive 
mtuu Mycobacterium tuberculosis BT2         Positive 
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Organism 
Code 
Species 
Absent H37Rv Homologs Relating to Cholesterol Catabolism 
Ability to 
Degrade 
Cholesterol 
Proven to be 
Essential 
Predicted to be 
Essential or 
Specifically 
Required 
Predicted to be 
Involved 
Involved but 
not Proven or 
Predicted to be 
Essential 
mabb Mycobacterium abscessus subsp. bolletii 50594 Rv3519 
Rv0876c 
Rv1906c 
Rv2684 
Rv3575c 
  
Rv3507 
Rv3508 
Rv3511 
Rv3514 
Rv3524 
Rv3528c 
Rv3566A 
Negative 
mmv Mycobacterium abscessus subsp. bolletii GO 06 Rv3519 
Rv0876c 
Rv2684 
Rv3575c 
  
Rv3507 
Rv3508 
Rv3511 
Rv3514 
Rv3524 
Rv3528c 
Rv3566A 
Negative 
may Mycobacterium abscessus subsp. bolletii MA 1948 Rv3519 
Rv1906c 
Rv2684 
  
Rv3507 
Rv3508 
Rv3511 
Rv3514 
Rv3524 
Rv3528c 
Rv3566A 
Negative 
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Organism 
Code 
Species 
Absent H37Rv Homologs Relating to Cholesterol Catabolism 
Ability to 
Degrade 
Cholesterol 
Proven to be 
Essential 
Predicted to be 
Essential or 
Specifically 
Required 
Predicted to be 
Involved 
Involved but 
not Proven or 
Predicted to be 
Essential 
mabo Mycobacterium abscessus subsp. bolletii MC1518 Rv3519 
Rv1906c 
Rv2684 
  
Rv3507 
Rv3508 
Rv3511 
Rv3514 
Rv3524 
Rv3528c 
Rv3566A 
Negative 
mabl 
Mycobacterium abscessus subsp. bolletii CCUG 48898 = JCM 
15300 
Rv3519 
Rv0876c 
Rv1906c 
Rv2684 
Rv3575c 
  
Rv3507 
Rv3508 
Rv3511 
Rv3514 
Rv3517 
Rv3524 
Rv3528c 
Rv3566A 
Negative 
maz Mycobacterium abscessus subsp. bolletii 103 Rv3519 
Rv1906c 
Rv2684 
  
Rv3507 
Rv3508 
Rv3511 
Rv3514 
Rv3524 
Rv3528c 
Rv3566A 
Negative 
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Organism 
Code 
Species 
Absent H37Rv Homologs Relating to Cholesterol Catabolism 
Ability to 
Degrade 
Cholesterol 
Proven to be 
Essential 
Predicted to be 
Essential or 
Specifically 
Required 
Predicted to be 
Involved 
Involved but 
not Proven or 
Predicted to be 
Essential 
mavi Mycobacterium avium subsp. paratuberculosis E1   
Rv0153c 
Rv1084 
  
Rv3528c 
Rv3566A 
Negative 
mavu Mycobacterium avium subsp. paratuberculosis E93       
Rv3528c 
Rv3566A 
Positive 
mav Mycobacterium avium 104   Rv3779   Rv3528c 
Rv3566A 
Negative 
mavd Mycobacterium avium subsp. avium DJO-44271   Rv0153c   
Rv3528c 
Rv3566A 
Negative 
mavr Mycobacterium avium subsp. avium 2285 (R)       
Rv3528c 
Rv3566A 
Positive 
mava Mycobacterium avium subsp. avium 2285 (S)       
Rv3528c 
Rv3566A 
Positive 
mit Mycobacterium intracellulare MOTT-02 Rv3519     
Rv3528c 
Rv3566A 
Negative 
mir Mycobacterium intracellulare MOTT-64       
Rv3528c 
Rv3566A 
Positive 
mia Mycobacterium intracellulare ATCC 13950       
Rv3528c 
Rv3566A 
Positive 
mie Mycobacterium intracellulare 1956       
Rv3528c 
Rv3566A 
Positive 
mid Mycobacterium indicus pranii       Rv3528c 
Rv3566A 
Positive 
myo Mycobacterium yongonense       
Rv3528c 
Rv3566A 
Positive 
mmm Mycobacterium sp. MOTT36Y       
Rv3528c 
Rv3566A 
Positive 
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Organism 
Code 
Species 
Absent H37Rv Homologs Relating to Cholesterol Catabolism 
Ability to 
Degrade 
Cholesterol 
Proven to be 
Essential 
Predicted to be 
Essential or 
Specifically 
Required 
Predicted to be 
Involved 
Involved but 
not Proven or 
Predicted to be 
Essential 
msb Mycobacterium smegmatis MC2 155 (2014)   
Rv0805 
Rv3572 
Rv3779 
  
Rv3507 
Rv3508 
Rv3511 
Rv3514 
Rv3528c 
Rv3566A 
Negative 
msn Mycobacterium smegmatis INHR1   
Rv0805 
Rv3493c 
Rv3572 
Rv3779 
  
Rv3507 
Rv3508 
Rv3511 
Rv3514 
Rv3528c 
Rv3566A 
Negative 
msh Mycobacterium smegmatis INHR2   
Rv0805 
Rv3572 
Rv3779 
  
Rv3507 
Rv3508 
Rv3511 
Rv3514 
Rv3528c 
Rv3566A 
Negative 
msa Mycobacterium sp. JS623   Rv1130   
Rv3507 
Rv3508 
Rv3511 
Rv3514 
Rv3517 
Rv3528c 
Negative 
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Organism 
Code 
Species 
Absent H37Rv Homologs Relating to Cholesterol Catabolism 
Ability to 
Degrade 
Cholesterol 
Proven to be 
Essential 
Predicted to be 
Essential or 
Specifically 
Required 
Predicted to be 
Involved 
Involved but 
not Proven or 
Predicted to be 
Essential 
mva Mycobacterium vanbaalenii   
Rv0805 
Rv1130 
Rv3572 
Rv3779 
  
Rv3507 
Rv3508 
Rv3511 
Rv3514 
Rv3517 
Rv3528c 
Rv3566A 
Negative 
mgi Mycobacterium gilvum PYR-GCK   
Rv0805 
Rv1130 
Rv3572 
Rv3779 
  
Rv3507 
Rv3508 
Rv3514 
Rv3528c 
Rv3566A 
Negative 
msp Mycobacterium gilvum Spyr1   
Rv0805 
Rv1084 
Rv1130 
Rv1919c 
Rv3492c 
Rv3572 
Rv3779 
  
Rv3507 
Rv3508 
Rv3511 
Rv3514 
Rv3528c 
Rv3566A 
Negative 
mmc Mycobacterium sp. MCS   
Rv0805 
Rv1130 
Rv3572 
Rv3779 
  
Rv3507 
Rv3508 
Rv3511 
Rv3514 
Rv3528c 
Rv3566A 
Negative 
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Organism 
Code 
Species 
Absent H37Rv Homologs Relating to Cholesterol Catabolism 
Ability to 
Degrade 
Cholesterol 
Proven to be 
Essential 
Predicted to be 
Essential or 
Specifically 
Required 
Predicted to be 
Involved 
Involved but 
not Proven or 
Predicted to be 
Essential 
mkm Mycobacterium sp. KMS   
Rv0805 
Rv1130 
Rv3572 
Rv3779 
  
Rv3507 
Rv3508 
Rv3511 
Rv3514 
Rv3528c 
Rv3566A 
Negative 
mjl Mycobacterium sp. JLS   
Rv0805 
Rv1130 
Rv3572 
Rv3779 
  
Rv3507 
Rv3508 
Rv3511 
Rv3514 
Rv3528c 
Rv3566A 
Negative 
mrh Mycobacterium rhodesiae   
Rv0805 
Rv1130 
Rv3572 
Rv3779 
  
Rv3507 
Rv3508 
Rv3514 
Rv3528c 
Rv3566A 
Negative 
mcb Mycobacterium chubuense   
Rv1130 
Rv2416c 
  
Rv3507 
Rv3508 
Rv3511 
Rv3514 
Rv3528c 
Rv3566A 
Rv3566c 
Negative 
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Organism 
Code 
Species 
Absent H37Rv Homologs Relating to Cholesterol Catabolism 
Ability to 
Degrade 
Cholesterol 
Proven to be 
Essential 
Predicted to be 
Essential or 
Specifically 
Required 
Predicted to be 
Involved 
Involved but 
not Proven or 
Predicted to be 
Essential 
mne Mycobacterium neoaurum   
Rv0805 
Rv3572 
Rv3779 
  
Rv3507 
Rv3508 
Rv3511 
Rv3514 
Rv3517 
Rv3528c 
Rv3566A 
Negative 
myv Mycobacterium sp. VKM Ac-1817D   
Rv0805 
Rv3572 
  
Rv3507 
Rv3508 
Rv3511 
Rv3514 
Rv3528c 
Negative 
mye Mycobacterium sp. EPa45   
Rv0876c 
Rv1130 
Rv2416c 
  
Rv3507 
Rv3508 
Rv3511 
Rv3517 
Rv3528c 
Rv3566A 
Rv3566c 
Negative 
mgo Mycobacterium goodii   
Rv0805 
Rv0876c 
Rv3572 
  
Rv3507 
Rv3508 
Rv3511 
Rv3514 
Rv3528c 
Rv3566A 
Negative 
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Organism 
Code 
Species 
Absent H37Rv Homologs Relating to Cholesterol Catabolism 
Ability to 
Degrade 
Cholesterol 
Proven to be 
Essential 
Predicted to be 
Essential or 
Specifically 
Required 
Predicted to be 
Involved 
Involved but 
not Proven or 
Predicted to be 
Essential 
mft Mycobacterium fortuitum   Rv3572   
Rv3507 
Rv3508 
Rv3511 
Rv3514 
Rv3528c 
Negative 
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3.4. Conclusion 
In conclusion, in silico comparative analysis of cholesterol using genes/proteins across 93 
mycobacterial species revealed the cholesterol-utilising capacity of mycobacterial species as 
shown in Table 3.15 below. 
 
Table 3.15. Analysis of cholesterol-utilising capability by mycobacterial species. 
Category No of species 
Ability to utilize cholesterol as carbon source 
Negative Positive 
MTBC 39 10 29 
MCAC 10 10   
MAC 15 5 10 
MCL 2 2   
NTM 8 5 3 
SAP 19 19   
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CHAPTER 4 
CONCLUSION AND FUTURE PERSPECTIVES 
 
In conclusion, the emergence of drug-resistant strains of Mycobacterium tuberculosis, along 
with the insufficiency of new drug targets, has necessitated research to identify novel drug 
targets.  Research is gaining momentum on the use of cholesterol-degrading genes as drug 
targets against M. tuberculosis.  In this direction this study is a first of its kind comprehensive 
analysis of genes/proteins involved in cholesterol degradation across 93 mycobacterial species 
using bioinformatic tools.  This study revealed that 42 of the 93 mycobacterial species selected 
for this study are capable of degrading cholesterol.  Fifty-one mycobacterial species were 
deduced to be unable to utilise cholesterol.  Results from this study are based on in silico 
analysis and need to be experimentally validated.  
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